<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">
<pmc-articleset><article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="review-article">
  <?properties open_access?>
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">Front Neurosci</journal-id>
      <journal-id journal-id-type="iso-abbrev">Front Neurosci</journal-id>
      <journal-id journal-id-type="publisher-id">Front. Neurosci.</journal-id>
      <journal-title-group>
        <journal-title>Frontiers in Neuroscience</journal-title>
      </journal-title-group>
      <issn pub-type="ppub">1662-4548</issn>
      <issn pub-type="epub">1662-453X</issn>
      <publisher>
        <publisher-name>Frontiers Media S.A.</publisher-name>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="pmid">24574954</article-id>
      <article-id pub-id-type="pmc">3918650</article-id>
      <article-id pub-id-type="doi">10.3389/fnins.2014.00016</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Neuroscience</subject>
          <subj-group>
            <subject>Mini Review Article</subject>
          </subj-group>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Adult subventricular zone neural stem cells as a potential source of dopaminergic replacement neurons</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name>
            <surname>Cave</surname>
            <given-names>John W.</given-names>
          </name>
          <xref ref-type="aff" rid="aff1">
            <sup>1</sup>
          </xref>
          <xref ref-type="aff" rid="aff2">
            <sup>2</sup>
          </xref>
          <xref ref-type="author-notes" rid="fn001">
            <sup>*</sup>
          </xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Wang</surname>
            <given-names>Meng</given-names>
          </name>
          <xref ref-type="aff" rid="aff1">
            <sup>1</sup>
          </xref>
          <xref ref-type="aff" rid="aff2">
            <sup>2</sup>
          </xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Baker</surname>
            <given-names>Harriet</given-names>
          </name>
          <xref ref-type="aff" rid="aff1">
            <sup>1</sup>
          </xref>
          <xref ref-type="aff" rid="aff2">
            <sup>2</sup>
          </xref>
        </contrib>
      </contrib-group>
      <aff id="aff1">
        <sup>1</sup>
        <institution>Brain and Mind Research Institute, Weill Cornell Medical College</institution>
        <country>New York, NY, USA</country>
      </aff>
      <aff id="aff2">
        <sup>2</sup>
        <institution>Burke Medical Research Institute</institution>
        <country>White Plains, NY, USA</country>
      </aff>
      <author-notes>
        <fn fn-type="edited-by">
          <p>Edited by: Antoine De Chevigny, Developmental Biology Institute of Marseille Luminy, France</p>
        </fn>
        <fn fn-type="edited-by">
          <p>Reviewed by: Luca Bonfanti, University of Turin, Italy; Umberto Di Porzio, Institute of Genetics and Biophysics &#x201C;Adriano Buzzati Traverso&#x201D;, Italy</p>
        </fn>
        <corresp id="fn001">*Correspondence: John W. Cave, Weill Cornell Medical College, Burke Medical Research Institute, 785 Mamaroneck Avenue, White Plains, NY, 10605, USA e-mail: <email xlink:type="simple">joc2042@med.cornell.edu</email></corresp>
        <fn fn-type="other" id="fn002">
          <p>This article was submitted to Neurogenesis, a section of the journal Frontiers in Neuroscience.</p>
        </fn>
      </author-notes>
      <pub-date pub-type="epub">
        <day>10</day>
        <month>2</month>
        <year>2014</year>
      </pub-date>
      <pub-date pub-type="collection">
        <year>2014</year>
      </pub-date>
      <volume>8</volume>
      <elocation-id>16</elocation-id>
      <history>
        <date date-type="received">
          <day>29</day>
          <month>11</month>
          <year>2013</year>
        </date>
        <date date-type="accepted">
          <day>22</day>
          <month>1</month>
          <year>2014</year>
        </date>
      </history>
      <permissions>
        <copyright-statement>Copyright &#xA9; 2014 Cave, Wang and Baker.</copyright-statement>
        <copyright-year>2014</copyright-year>
        <license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by/3.0/">
          <license-p>This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</license-p>
        </license>
      </permissions>
      <abstract>
        <p>Clinical trials engrafting human fetal ventral mesencephalic tissue have demonstrated, in principle, that cell replacement therapy provides substantial long-lasting improvement of motor impairments generated by Parkinson's Disease (PD). The use of fetal tissue is not practical for widespread clinical implementation of this therapy, but stem cells are a promising alternative source for obtaining replacement cells. The ideal stem cell source has yet to be established and, in this review, we discuss the potential of neural stem cells in the adult subventricular zone (SVZ) as an autologous source of replacement cells. We identify three key challenges for further developing this potential source of replacement cells: (1) improving survival of transplanted cells, (2) suppressing glial progenitor proliferation and survival, and (3) developing methods to efficiently produce dopaminergic neurons. Subventricular neural stem cells naturally produce a dopaminergic interneuron phenotype that has an apparent lack of vulnerability to PD-mediated degeneration. We also discuss whether olfactory bulb dopaminergic neurons derived from adult SVZ neural stem cells are a suitable source for cell replacement strategies.</p>
      </abstract>
      <kwd-group>
        <kwd>subventricular zone</kwd>
        <kwd>olfactory bulb</kwd>
        <kwd>neural stem cells</kwd>
        <kwd>adult neurogenesis</kwd>
        <kwd>dopaminergic</kwd>
        <kwd>cell replacement therapy</kwd>
      </kwd-group>
      <counts>
        <fig-count count="0"/>
        <table-count count="1"/>
        <equation-count count="0"/>
        <ref-count count="94"/>
        <page-count count="8"/>
        <word-count count="7462"/>
      </counts>
    </article-meta>
  </front>
  <body>
    <sec id="s1">
      <title>Introduction</title>
      <p>Parkinson's Disease (PD) is one of the most prevalent neurodegenerative disorders and afflicts ~1% of the population over 60 years of age in industrialized nations (Nussbaum and Ellis, <xref rid="B63" ref-type="bibr">2003</xref>). PD affects several regions of the nervous system that result in many clinical symptoms (Braak et al., <xref rid="B8" ref-type="bibr">2004</xref>; Poewe, <xref rid="B68" ref-type="bibr">2008</xref>). The most characteristic symptoms, however, are motor system impairments that include tremor, rigidity, and bradykinesia. The pathology underlying these motor symptoms is a progressive degeneration of dopaminergic neurons in the substantia nigra pars compacta. These dopamine neurons modulate control of motor function through axonal projections to the putamen and caudate divisions of the striatum. Standard clinical care is focused on the functional preservation of this nigrostriatal circuit. Pharmacological approaches with L-DOPA and dopamine receptor agonists can ameliorate most motor symptoms, particularly in the early stages after a clinical diagnosis. As the disease progresses, however, medication regimens become less effective and surgical strategies, such as deep brain stimulation, can provide symptomatic relief. Both the pharmacological and surgical interventions ultimately fail though because they do not stop the progressive degeneration of midbrain dopaminergic neurons.</p>
      <p>Cell replacement strategies are a fundamentally different type of therapy because they introduce new dopaminergic neurons that can restore striatal dopamine levels. Clinical trials engrafting human fetal ventral mesencephalic tissue containing dopaminergic neuronal progenitors into the striatum demonstrated, in principle, that this approach can provide substantial long-lasting improvement of motor symptoms (Widner et al., <xref rid="B87" ref-type="bibr">1992</xref>; Defer et al., <xref rid="B20" ref-type="bibr">1996</xref>; Freed et al., <xref rid="B24" ref-type="bibr">2001</xref>; Mendez et al., <xref rid="B58" ref-type="bibr">2002</xref>; Olanow et al., <xref rid="B64" ref-type="bibr">2003</xref>). Some patients in these trials improved post-operatively to a point where L-DOPA therapy was no longer required, but others experienced negligible long-term improvement and, in some cases, severe graft-induced dyskinesias developed and required additional surgical intervention.</p>
    </sec>
    <sec>
      <title>Ideal features of replacement cell sources</title>
      <p>Analyses of the clinical trials identified several features of replacement cells that are essential for favorable functional outcomes (Wijeyekoon and Barker, <xref rid="B88" ref-type="bibr">2009</xref>; Lindvall and Bjorklund, <xref rid="B49" ref-type="bibr">2011</xref>). These features include establishing replacement cell sources that are autologous, or at the least allogenic, since immunosuppression appears to improve engrafted cell survival and clinical outcomes (Olanow et al., <xref rid="B64" ref-type="bibr">2003</xref>). The survival rate of transplanted cells is an important practical issue and sources that provide replacement cells with higher survival rates reduce the total amount of donor material required. Significant clinical benefit is estimated to require the survival of at least 100,000 engrafted dopaminergic neurons per putamen (Hagell and Brundin, <xref rid="B33" ref-type="bibr">2001</xref>). Clinical improvement is also more likely achieved with sources that can be used as dissociated cell suspensions. Unlike solid tissue grafts, cell suspensions can readily disperse and evenly innervate target areas. Studies of engraftments in both humans and rodents indicate the uneven and patchy reinnervation of the putamen promotes the development of adverse dyskinesia side effects (Ma et al., <xref rid="B54" ref-type="bibr">2002</xref>; Carlsson et al., <xref rid="B11" ref-type="bibr">2006</xref>; Maries et al., <xref rid="B55" ref-type="bibr">2006</xref>). The risk of dyskinesias is also reduced with replacement cell sources that can be prepared by standardized protocols that minimize the presence of undesired phenotypes. The presence of serotonergic progenitors in fetal mesencephalic tissue, for example, is believed to contribute to the incidence of transplant-related dyskinesias (Politis et al., <xref rid="B69" ref-type="bibr">2012</xref>). Consistent with this possibility, serotonergic neurons transplanted into the striatum of rodent PD models exacerbate dyskinesias induced by L-DOPA (Carlsson et al., <xref rid="B10" ref-type="bibr">2007</xref>).</p>
    </sec>
    <sec>
      <title>Embryonic and induced pluripotent stem cell sources</title>
      <p>The ideal source of replacement cells for PD has not been established (reviewed in Meyer et al., <xref rid="B61" ref-type="bibr">2010</xref>). Fetal mesencephalic tissue is not practical because of the difficulty in standardizing donor tissue and ethical concerns of how to generate the necessary amounts of material required for widespread clinical use. Stem cells, however, are a promising source of replacement cells that meet the requirements for creating favorable clinical outcomes (discussed above). Several studies have demonstrated the feasibility of stem cell based therapies using embryonic stem cells (Bjorklund et al., <xref rid="B6" ref-type="bibr">2002</xref>; Kim et al., <xref rid="B41" ref-type="bibr">2002</xref>; Takagi et al., <xref rid="B81" ref-type="bibr">2005</xref>; Roy et al., <xref rid="B73" ref-type="bibr">2006</xref>; Rodriguez-Gomez et al., <xref rid="B72" ref-type="bibr">2007</xref>; Cho et al., <xref rid="B16" ref-type="bibr">2008</xref>; Sanchez-Pernaute et al., <xref rid="B75" ref-type="bibr">2008</xref>; Friling et al., <xref rid="B25" ref-type="bibr">2009</xref>). These studies used a variety of differentiation protocols, but they all showed that transplants of embryonic stem cell-derived dopaminergic neurons into either rodent or primate PD model systems both survive and integrate into the host circuitry to provide significant functional recovery. Embryonic stem cells face several important challenges, however, before they can be considered for human clinical trials. These challenges include developing higher efficiency protocols for dopaminergic neuron production, improving survival of engrafted cells, and methods to completely remove contaminating cell types responsible for tumor or teratoma formation observed in animal trials.</p>
      <p>Induced pluripotent stem cells are another potential source of replacement cells. Their broad differentiation potential resembles embryonic stem cells, but the ability to derive these cells from adult tissue avoids the moral and ethical issues of using embryonic stem cell lines. Furthermore, induced pluripotent stem cells are a potential autologous source of replacement cells since they can be generated from a patient's own cells. Recent reports indicate that dopaminergic neurons derived from induced pluripotent stem cells can survive and provide functional improvement in rodent PD model systems (Wernig et al., <xref rid="B85" ref-type="bibr">2008</xref>; Hargus et al., <xref rid="B34" ref-type="bibr">2010</xref>; Swistowski et al., <xref rid="B80" ref-type="bibr">2010</xref>; Rhee et al., <xref rid="B70" ref-type="bibr">2011</xref>; Chang et al., <xref rid="B13" ref-type="bibr">2012</xref>; Sundberg et al., <xref rid="B79" ref-type="bibr">2013</xref>). Advancing induced pluripotent stem cells to a clinical setting faces many of same challenges confronting the use of embyronic stem cells, including improvement in the dopaminergic neuron yields and prevention of tumor formation in the recipient.</p>
    </sec>
    <sec>
      <title>Replacement cells derived from the adult SVZ</title>
      <sec>
        <title>Adult neural stem cells</title>
        <p>Neural stem cells are an alternative source of replacement neurons. These cells lack the pluripotent potential of embryonic and induced pluripotent stem cells, but they also do not have the same teratoma or tumor forming potential. Fetal tissue is a rich source of neural stem cells that can generate a wide array of neuronal phenotypes, but as discussed above, the use of fetal tissue is fraught with moral and ethical problems. By contrast, adult neural stem cells do not have these issues, although they typically generate a more limited number of neuronal phenotypes. In the adult mammalian brain, there are two well-established neurogenic niches: the hippocampal subgranular zone and the subventricular zone (SVZ) of the lateral ventricles (Gage et al., <xref rid="B27" ref-type="bibr">2008</xref>; Seki et al., <xref rid="B77" ref-type="bibr">2011</xref>). Neurons generated in both of these regions are able to integrate into pre-existing neural circuitry, which makes them attractive candidates for cell replacement therapy. Progenitors generated in the subgranular zone migrate to the dentate gyrus and become excitatory glutamatergic granule cells. Subgranular zone neural stem cells are located within the interior of the hippocampus, however, and extracting them without damaging the hippocampus is difficult. SVZ neural stem cells almost exclusively produce inhibitory GABAergic inhibitory interneuron progenitors that migrate to the olfactory bulb glomerular and granule cells layers (production of a small number of excitatory neurons has also been reported in Brill et al., <xref rid="B9" ref-type="bibr">2009</xref>). SVZ neural stem cells reside within the walls of the lateral ventricle and, by penetrating non-eloquent parts of the brain in humans, they can be endoscopically harvested, expanded <italic>in vitro</italic> and differentiated into both neuronal and glial progenitors (Westerlund et al., <xref rid="B86" ref-type="bibr">2005</xref>). Thus, adult SVZ neural stem cells are a potential clinically feasible source of autologous replacement neurons.</p>
      </sec>
      <sec>
        <title>Transplantation of adult SVZ cells into the striatum</title>
        <p>Several studies have homochronously transplanted either SVZ tissue explants or suspensions of either neurospheres or dissociated cells into the adult rodent striatum (Table <xref ref-type="table" rid="T1">1</xref>) (Lois and Alvarez-Buylla, <xref rid="B50" ref-type="bibr">1994</xref>; Herrera et al., <xref rid="B35" ref-type="bibr">1999</xref>; Zhang et al., <xref rid="B93" ref-type="bibr">2003</xref>; Meissner et al., <xref rid="B57" ref-type="bibr">2005</xref>; Richardson et al., <xref rid="B71" ref-type="bibr">2005</xref>; Seidenfaden et al., <xref rid="B76" ref-type="bibr">2006</xref>; Chen et al., <xref rid="B14" ref-type="bibr">2007a</xref>,<xref rid="B15" ref-type="bibr">b</xref>; Shim et al., <xref rid="B78" ref-type="bibr">2007</xref>; Deleidi et al., <xref rid="B21" ref-type="bibr">2011</xref>). Similar to other sources of donor cells, the survival rates of transplanted SVZ cells were consistently low. Also similar to clinical trials with fetal tissue, migration of transplanted SVZ cells away from the injection site was greater with dispersed SVZ cultures or neurospheres than with engraftments of tissue explants.</p>
        <table-wrap id="T1" position="float">
          <label>Table 1</label>
          <caption>
            <p><bold>Summary of studies transplanting adult SVZ-derived cells into the adult striatum</bold>.</p>
          </caption>
          <table frame="hsides" rules="groups">
            <thead>
              <tr>
                <th align="left" rowspan="1" colspan="1">
                  <bold>Study</bold>
                </th>
                <th align="left" rowspan="1" colspan="1">
                  <bold>Type of SVZ tissue transplanted</bold>
                </th>
                <th align="left" rowspan="1" colspan="1">
                  <bold>Donor species and genotype</bold>
                </th>
                <th align="left" rowspan="1" colspan="1">
                  <bold>Modifications to donor SVZ tissue prior to transplantation</bold>
                </th>
                <th align="left" rowspan="1" colspan="1">
                  <bold>Recipient species and phenotype</bold>
                </th>
                <th align="left" rowspan="1" colspan="1">
                  <bold>Analysis of recipient animals post-transplantation</bold>
                </th>
                <th align="left" rowspan="1" colspan="1">
                  <bold>Key findings</bold>
                </th>
              </tr>
            </thead>
            <tbody>
              <tr>
                <td align="left" rowspan="1" colspan="1">Lois and Alvarez-Buylla, <xref rid="B50" ref-type="bibr">1994</xref></td>
                <td align="left" rowspan="1" colspan="1">~100 &#x3BC;m diameter explants</td>
                <td align="left" rowspan="1" colspan="1">NSE-LacZ mice</td>
                <td align="left" rowspan="1" colspan="1">None</td>
                <td align="left" rowspan="1" colspan="1">Wild-type mice</td>
                <td align="left" rowspan="1" colspan="1">30 days</td>
                <td align="left" rowspan="1" colspan="1">No migration of surviving cells outside of transplantation site</td>
              </tr>
              <tr>
                <td align="left" rowspan="1" colspan="1">Herrera et al., <xref rid="B35" ref-type="bibr">1999</xref></td>
                <td align="left" rowspan="1" colspan="1">~150 &#x3BC;m diameter explants</td>
                <td align="left" rowspan="1" colspan="1">NSE-LacZ mice</td>
                <td align="left" rowspan="1" colspan="1">None</td>
                <td align="left" rowspan="1" colspan="1">Mice with kainic acid lesions</td>
                <td align="left" rowspan="1" colspan="1">2, 4, 6, and 8 weeks</td>
                <td align="left" rowspan="1" colspan="1">Limited migration of transplanted cells Vast majority of surviving NSE-LacZ expressing cells were astrocytes</td>
              </tr>
              <tr>
                <td align="left" rowspan="1" colspan="1">Zhang et al., <xref rid="B93" ref-type="bibr">2003</xref></td>
                <td align="left" rowspan="1" colspan="1">Dissociated cell suspensions</td>
                <td align="left" rowspan="1" colspan="1">Wild-type rat</td>
                <td align="left" rowspan="1" colspan="1">Neural progenitor cells cultured for 8 days in media with FGF2, horse and calf serum; cells were labeled with either BrdU or DiO</td>
                <td align="left" rowspan="1" colspan="1">Wild-type rats</td>
                <td align="left" rowspan="1" colspan="1">7 and 28 days</td>
                <td align="left" rowspan="1" colspan="1">Substantial migration away from transplantation site Majority of BrdU and DiO labeled cells expressed either MAP2 or NeuN, few expressed GFAP</td>
              </tr>
              <tr>
                <td align="left" rowspan="1" colspan="1">Meissner et al., <xref rid="B57" ref-type="bibr">2005</xref></td>
                <td align="left" rowspan="1" colspan="1">Neurosphere suspensions</td>
                <td align="left" rowspan="1" colspan="1">&#x3B2;Actin-CMV-GFP mice</td>
                <td align="left" rowspan="1" colspan="1">Neurospheres were cultured for 5 passages in the presence of EGF and FGF2</td>
                <td align="left" rowspan="1" colspan="1">Mice with unilateral 6-hydroxydopamine OHDA lesions</td>
                <td align="left" rowspan="1" colspan="1">1 month</td>
                <td align="left" rowspan="1" colspan="1">Low survival rate of transplanted cells ~7% and ~2% of surviving cells expressed TH Improved motor performance to apomorphine and amphetamine challenges</td>
              </tr>
              <tr>
                <td align="left" rowspan="1" colspan="1">Richardson et al., <xref rid="B71" ref-type="bibr">2005</xref></td>
                <td align="left" rowspan="1" colspan="1">Dissociated cell suspensions</td>
                <td align="left" rowspan="1" colspan="1">Wild-type rat</td>
                <td align="left" rowspan="1" colspan="1">Neural progenitor cells isolated by a Percoll gradient, cultured for 1 week in media containing FGF2, then 6 days in media containing retinoic acid without FGF2; cells were labeled with BrdU</td>
                <td align="left" rowspan="1" colspan="1">Rats with unilateral 6-hydroxydopamine OHDA lesions</td>
                <td align="left" rowspan="1" colspan="1">2 weeks</td>
                <td align="left" rowspan="1" colspan="1">Many surviving transplanted cells maintain Nestin expression, but none expressed NeuN Improved motor performance to amphetamine challenge</td>
              </tr>
              <tr>
                <td align="left" rowspan="1" colspan="1">Seidenfaden et al., <xref rid="B76" ref-type="bibr">2006</xref></td>
                <td align="left" rowspan="1" colspan="1">~100 &#x3BC;m diameter explants</td>
                <td align="left" rowspan="1" colspan="1">&#x3B2;Actin-CMV-GFP mice</td>
                <td align="left" rowspan="1" colspan="1">None</td>
                <td align="left" rowspan="1" colspan="1">Wild-type mice</td>
                <td align="left" rowspan="1" colspan="1">3 weeks and 6 months</td>
                <td align="left" rowspan="1" colspan="1">Limited migration and low survival rate of transplanted cells Most surviving cells expressed glial marker genes</td>
              </tr>
              <tr>
                <td align="left" rowspan="1" colspan="1">Chen et al., <xref rid="B15" ref-type="bibr">2007b</xref></td>
                <td align="left" rowspan="1" colspan="1">Neurosphere suspensions</td>
                <td align="left" rowspan="1" colspan="1">Wild-type rat</td>
                <td align="left" rowspan="1" colspan="1">Neural progenitor cells isolated by a Percoll gradient protocol, cultured for 2 weeks in media containing EGF and FGF2; cells were labeled with BrdU</td>
                <td align="left" rowspan="1" colspan="1">Wild-type rat</td>
                <td align="left" rowspan="1" colspan="1">6 weeks</td>
                <td align="left" rowspan="1" colspan="1">Substantial migration away from transplantation site Most surviving cells expressed GFAP and none expressed NeuN</td>
              </tr>
              <tr>
                <td align="left" rowspan="1" colspan="1">Chen et al., <xref rid="B14" ref-type="bibr">2007a</xref></td>
                <td align="left" rowspan="1" colspan="1">Neurosphere suspensions</td>
                <td align="left" rowspan="1" colspan="1">Wild-type rat</td>
                <td align="left" rowspan="1" colspan="1">Neural progenitor cells isolated by a Percoll gradient protocol, cultured for 2 weeks in media containing EGF and FGF2; cells were labeled with BrdU</td>
                <td align="left" rowspan="1" colspan="1">Rats transduced with AAV<sub>1/2</sub> vectors to over-express either BDNF or FGF2 in the striatum</td>
                <td align="left" rowspan="1" colspan="1">6 and 12 weeks</td>
                <td align="left" rowspan="1" colspan="1">AAV<sub>1/2</sub>-FGF2 improved survival of transplanted cells Most surviving transplanted cells expressed glial marker genes AAV<sub>1/2</sub>-BDNF increased percentage of surviving cells expressing NeuN</td>
              </tr>
              <tr>
                <td align="left" rowspan="1" colspan="1">Shim et al., <xref rid="B78" ref-type="bibr">2007</xref></td>
                <td align="left" rowspan="1" colspan="1">Dissociated cell suspensions</td>
                <td align="left" rowspan="1" colspan="1">Wild-type rat</td>
                <td align="left" rowspan="1" colspan="1">Neurospheres were cultured in media containing EGF, FGF2, and PDGF for over 2 months; retroviral transduction to over-express Nurr1 and Mash1</td>
                <td align="left" rowspan="1" colspan="1">Rats with unilateral 6-hydroxydopamine OHDA lesions</td>
                <td align="left" rowspan="1" colspan="1">2, 4, and 6 weeks</td>
                <td align="left" rowspan="1" colspan="1">Substantial number of surviving transplanted cells expressed MAP2, TH and VMAT2 Improved motor performance to amphetamine challenge</td>
              </tr>
              <tr>
                <td align="left" rowspan="1" colspan="1">Deleidi et al., <xref rid="B21" ref-type="bibr">2011</xref></td>
                <td align="left" rowspan="1" colspan="1">Dissociated cell suspensions</td>
                <td align="left" rowspan="1" colspan="1">rTA/Oct4 mice</td>
                <td align="left" rowspan="1" colspan="1">Neurospheres were expanded for 14 days before being converted to induced pluripotent stem cells and then differentiated via 5 stage protocol; SSEA1+ cells were removed by cell sorting prior to transplantation</td>
                <td align="left" rowspan="1" colspan="1">Rats with unilateral 6-hydroxydopamine OHDA lesions</td>
                <td align="left" rowspan="1" colspan="1">4, 6, and 8 weeks</td>
                <td align="left" rowspan="1" colspan="1">Substantial number of surviving transplanted cells express TH Improved motor performance to apomorphine and amphetamine challenges</td>
              </tr>
            </tbody>
          </table>
        </table-wrap>
        <p>An unexpected and consistent finding in the rodent studies with SVZ-derived cells was the meager differentiation and survival of transplanted neurons. Using either cell suspensions or tissue explants as donor material, many of the surviving cells displayed glial phenotypes and very few expressed markers of mature neurons. The poor neuron yields were surprising since the adult SVZ normally produces large numbers of neuronal progenitors (Luskin, <xref rid="B53" ref-type="bibr">1993</xref>; Lois and Alvarez-Buylla, <xref rid="B50" ref-type="bibr">1994</xref>). Analyses of SVZ progenitor cultures expanded <italic>in vitro</italic> found a large percentage of cells expressed glial marker genes prior to transplantation (Richardson et al., <xref rid="B71" ref-type="bibr">2005</xref>; Chen et al., <xref rid="B15" ref-type="bibr">2007b</xref>), suggesting that <italic>in vitro</italic> culture conditions may preferentially select for glial precursors. An exception is a study by Zhang and co-workers that reported achieving a high percentage (~70%) of neuronal precursors in SVZ cultures prior to transplantation (Zhang et al., <xref rid="B93" ref-type="bibr">2003</xref>). A majority of cells that survived a month after transplantation were found to have a mature a neuronal phenotype and only a few cells expressed the glial marker GFAP. The reasons for higher levels of neuronal generation and survival in this study are unclear. The interactions between adult SVZ neural stem cells and their surrounding niche are complex and only just becoming understood (reviewed in Ihrie and Alvarez-Buylla, <xref rid="B38" ref-type="bibr">2011</xref>). Despite their poor neuronal differentiation and survival, transplants of SVZ-derived cells into the host striatum did provide some functional recovery in 6-hydroxydopamine lesioned rodent PD models a month after surgery (Meissner et al., <xref rid="B57" ref-type="bibr">2005</xref>; Richardson et al., <xref rid="B71" ref-type="bibr">2005</xref>). The extent of the improvement was variable, but it does suggest that introduction of glia is not deleterious and may produce some short-term symptomatic improvement.</p>
      </sec>
      <sec>
        <title>Dopaminergic differentiation of SVZ progenitors</title>
        <p>In addition to the poor differentiation and survival of neurons with SVZ-cell transplants, few, if any, of the detectable neurons displayed dopaminergic features. The human clinical trials clearly showed that integration and survival of dopaminergic neurons is essential for sustained long-term functional improvement. Embryonic and induced pluripotent stem cells can be directed toward a dopaminergic cell fate by culturing them with appropriate growth factors and morphogens (Kriks and Studer, <xref rid="B45" ref-type="bibr">2009</xref>; Boyer et al., <xref rid="B7" ref-type="bibr">2012</xref>). Similar protocols can significantly improve neuronal progenitor yields in cultured SVZ cells, but they do not direct these cells to a dopaminergic cell fate (Deleidi et al., <xref rid="B21" ref-type="bibr">2011</xref>). These protocols can generate dopaminergic neurons, however, if the SVZ progenitors are first converted into pluripotent stem cells by <italic>Oct4</italic> over-expression (Deleidi et al., <xref rid="B21" ref-type="bibr">2011</xref>). <italic>Oct4</italic> has a central role in stem cell pluripotency and differentiation, and is sufficient to reprogram adult neural stem cells into pluripotent stem cells (Pesce and Scholer, <xref rid="B66" ref-type="bibr">2001</xref>; Kim et al., <xref rid="B40" ref-type="bibr">2009</xref>). About 5% of the total cells in culture can be directed to adopt a midbrain dopaminergic neuronal phenotype when SVZ progenitors are reprogrammed by <italic>Oct4</italic> over-expression. Transplantation of cultures with these reprogrammed dopaminergic neurons into 6-hydroxydopamine lesioned rats produced significant and reproducible functional improvement for up to 2 months after the procedure (Deleidi et al., <xref rid="B21" ref-type="bibr">2011</xref>).</p>
        <p>An alternative genetic engineering strategy for improving dopaminergic neuron yields is to over-express transcription factors that specify cell fate during normal development. This approach has been successfully used with both embryonic and induced pluripotent stem cells (Chung et al., <xref rid="B18" ref-type="bibr">2002</xref>, <xref rid="B17" ref-type="bibr">2005</xref>; Kim et al., <xref rid="B41" ref-type="bibr">2002</xref>; Andersson et al., <xref rid="B4" ref-type="bibr">2006</xref>; Martinat et al., <xref rid="B56" ref-type="bibr">2006</xref>; Friling et al., <xref rid="B25" ref-type="bibr">2009</xref>; Sanchez-Danes et al., <xref rid="B74" ref-type="bibr">2012</xref>; Theka et al., <xref rid="B82" ref-type="bibr">2013</xref>). Both <italic>Mash-1</italic> and <italic>Nurr1</italic> genes encode transcription factors that are involved in the specification of midbrain dopaminergic neurons (Park et al., <xref rid="B65" ref-type="bibr">2006</xref>). Retroviral-mediated over-expression of these transcription factors can direct a substantial percentage (~37%) of the total number of cultured adult SVZ cells to express dopaminergic neuronal markers (Shim et al., <xref rid="B78" ref-type="bibr">2007</xref>). Transplantation of these cells in 6-hydroxydopamine lesioned rats also produces robust functional improvement.</p>
      </sec>
      <sec>
        <title>SVZ/olfactory bulb dopaminergic phenotype as a potential replacement cell source</title>
        <p>Adult SVZ neural stem cells normally generate dopaminergic interneurons and both <italic>Mash1</italic> and <italic>Nurr1</italic>-family transcription factors are important for specification of these interneurons (Cave and Baker, <xref rid="B12" ref-type="bibr">2009</xref>). Although the over-expression of <italic>Mash1</italic> and <italic>Nurr1</italic> was intended to generate dopaminergic neurons with a midbrain phenotype, this strategy may have generated either A16 olfactory bulb dopaminergic neurons or hybrid A16 neurons. The ability of the dopaminergic neurons generated by Shim and co-workers to significantly improve functional performance in the rodent PD model, raises the possibility that either an A16 or a hybrid A16 dopaminergic neuron is a viable alternative for cell replacement strategies.</p>
        <p>Non-midbrain dopaminergic neurons are not typically considered for replacement cells in PD. This is due, in part, to studies of transplanted dopaminergic neurons from non-mesencepahlic brain regions. Grafts of diencephalic dopaminergic neurons from either rodent or human embryonic hypothalamic tissue poorly integrated into the host striatum and provided no significant functional benefit in PD models (Abrous et al., <xref rid="B1" ref-type="bibr">1988</xref>; Zuddas et al., <xref rid="B94" ref-type="bibr">1991</xref>; Frodl et al., <xref rid="B26" ref-type="bibr">1994</xref>). Furthermore, previous clinical trials grafting tissue containing catecholaminergic neurons from non-brain regions, including the adrenal medulla, carotid body, retinal epithelium and sympathetic ganglion neurons, demonstrated either only marginal or no significant benefit. In addition, morbidities associated some procedures, such as autografts of either adrenal medulla and sympathetic ganglia, have further discouraged exploration of non-midbrain phenotypes as replacement cells (reviewed in Wijeyekoon and Barker, <xref rid="B88" ref-type="bibr">2009</xref>).</p>
        <p>Olfactory bulb dopaminergic neurons have several favorable attributes, however, that are distinct from these previously tested non-midbrain phenotypes. Like other adult-generated neurons, olfactory bulb dopaminergic progenitors can integrate into pre-existing neural circuitry. Mature neurons are likely able to innervate large areas of striatum since they have processes that typically extend for over 200 &#x3BC;m and, in some cases, over 700 &#x3BC;m (Kiyokage et al., <xref rid="B42" ref-type="bibr">2010</xref>). Like their counterparts in the substantia nigra, a prominent electrophysiological property of olfactory bulb dopaminergic neurons is a capacity to generate auto-rhythmic action potentials (Pignatelli et al., <xref rid="B67" ref-type="bibr">2005</xref>; Guzman et al., <xref rid="B32" ref-type="bibr">2009</xref>). Unlike the substantia nigra, however, olfactory bulb dopaminergic neurons are not vulnerable in PD-mediated neurodegeneration (Huisman et al., <xref rid="B37" ref-type="bibr">2004</xref>). Consistent with this reduced vulnerability, olfactory bulb dopaminergic neurons lack &#x3B1;-synuclein deposits in rodents over-expressing this protein (Ubeda-Banon et al., <xref rid="B84" ref-type="bibr">2010</xref>). Several PD patients surviving at least 10 years after intrastriatal grafts of fetal mesencephalic tissue have shown accumulation of &#x3B1;-synuclein in grafted neurons (Kordower et al., <xref rid="B43" ref-type="bibr">2008a</xref>,<xref rid="B44" ref-type="bibr">b</xref>; Li et al., <xref rid="B46" ref-type="bibr">2008</xref>, <xref rid="B47" ref-type="bibr">2010</xref>; Mendez et al., <xref rid="B59" ref-type="bibr">2008</xref>). Whether this accumulation adversely affects the function or survival of replacement neurons is not known, but it does suggest that replacement neurons of the midbrain phenotype are susceptible to PD in the long-term. Replacement neurons with the olfactory bulb dopaminergic phenotype, however, are expected to be less vulnerable to this pathology.</p>
      </sec>
      <sec>
        <title>Challenges for developing adult SVZ cells as replacement cells</title>
        <p>Developing adult SVZ cells into a clinically suitable autologous source of replacement neurons faces several challenges. One challenge is to enhance survival rates of engrafted cells. Studies with embryonic and induced pluripotent stem cells, for which long-term survival is also an issue, have indicated that treating the donor cells with antioxidants or growth factors can increase survival rates (Nakao et al., <xref rid="B62" ref-type="bibr">1994</xref>; Apostolides et al., <xref rid="B5" ref-type="bibr">1998</xref>; Espejo et al., <xref rid="B23" ref-type="bibr">2000</xref>; Hoglinger et al., <xref rid="B36" ref-type="bibr">2001</xref>; Andereggen et al., <xref rid="B3" ref-type="bibr">2009</xref>). The presence of neurotransmitters in the culture conditions may improve the ability to expand and differentiate cells with neuronal phenotypes since neurotransmitters can modulate proliferation, migration and survival of SVZ-derived cells in the endogenous SVZ neurogenic niche (reviewed in Young et al., <xref rid="B91" ref-type="bibr">2011</xref>). In addition, pre-conditioning recipients by administering growth factors may also be an important strategy to improve long-term survival (Chen et al., <xref rid="B14" ref-type="bibr">2007a</xref>). Elucidating culture conditions that promote neuronal progenitor expansion and survival will be critical for developing standardized preparations to generate clinically suitable replacement cells from adult SVZ neural stem cells.</p>
        <p>A second challenge is the suppression of glial progenitor proliferation and survival. SVZ neural stem cells prodigiously generate neuronal progenitors in their endogenous niche, but most of the progenitors generated by these cells either do not to survive or they adopt alternative fates when cultured <italic>in vitro</italic> and transplanted into the striatum. Furthermore, proportional levels of glial production increase with either the age of the SVZ neural stem cell donor or the length of time that the stem cells are cultured (Gritti et al., <xref rid="B31" ref-type="bibr">2009</xref>). Since most PD patients are advanced in age, the propensity of autologously derived SVZ stem cells to produce glia is an important challenge to address. Protocols for <italic>in vitro</italic> expansion of SVZ progenitors typically use growth factor combinations that include epidermal growth factor (EGF) (Deleyrolle and Reynolds, <xref rid="B22" ref-type="bibr">2009</xref>). The inclusion of this growth factor, however, may be detrimental for neuronal progenitor production since stimulation of EGF receptors promotes glial progenitor proliferation and differentiation in the SVZ (Aguirre and Gallo, <xref rid="B2" ref-type="bibr">2007</xref>; Gonzalez-Perez and Quinones-Hinojosa, <xref rid="B30" ref-type="bibr">2010</xref>; Gonzalez-Perez and Alvarez-Buylla, <xref rid="B29" ref-type="bibr">2011</xref>). Alternatively, culture media may require other growth factors to suppress glial differentiation. Expansion of neurospheres derived from the adult SVZ in media containing both EGF and FGF9 enhances neuronal proliferation while diminishing both oligodendrocyte and astrocyte progenitor production (Lum et al., <xref rid="B52" ref-type="bibr">2009</xref>). Supplementing <italic>in vitro</italic> culture conditions with Noggin may also enhance suppression of glial phenotypes. SVZ neural stem cells and neural progenitors express BMP receptors and antagonism of these receptors by Noggin inhibits glial differentiation (Lim et al., <xref rid="B48" ref-type="bibr">2000</xref>). Furthermore, cell-sorting techniques can facilitate the removal of glial progenitors from SVZ-derived cultures prior to transplantation. Recent studies with human pluripotent progenitors showed that glial progenitors can be successfully isolated from mixed cultures based on co-expression of CD44 and CD184 (Yuan et al., <xref rid="B92" ref-type="bibr">2011</xref>).</p>
        <p>A third challenge is developing efficient methods to produce dopaminergic neurons. Treatment either with growth factors, morphogens, signaling molecules, or chromatin modifying agents does not direct SVZ-derived progenitors toward a dopaminergic fate. By contrast, significant dopaminergic neuron production has been only achieved through genetic modification of SVZ-derived progenitors (Shim et al., <xref rid="B78" ref-type="bibr">2007</xref>; Deleidi et al., <xref rid="B21" ref-type="bibr">2011</xref>). These genetic engineering methods, however, come with some caveats. Reprogramming of SVZ neural stem cells into pluripotent cells prior to dopaminergic differentiation introduces the same safety concerns associated with induced pluripotent stem cell strategies. Retroviral transduction of SVZ progenitors to over-express transcription factor genes, such as <italic>Nurr1</italic> and <italic>Mash1</italic>, avoids the concerns of genetic reprogramming, but retroviruses are questionable for clinical application since they can increase the risk of tumor formation by disrupting endogenous gene expression upon their insertion into the host genome (Yi et al., <xref rid="B89" ref-type="bibr">2011</xref>). Genetically engineering SVZ progenitors for cell replacement therapy in PD will likely require one of the other available methods to transduce cells (Lowry and Plath, <xref rid="B51" ref-type="bibr">2008</xref>).</p>
        <p>Even though over-expression of <italic>Nurr1</italic> and <italic>Mash1</italic> has provided the best yield of SVZ-derived dopaminergic neurons to date, only a subset of transduced cells adopted a dopaminergic phenotype. This partial induction may reflect the heterogeneity within the SVZ stem cell niche. Specific subsets of olfactory bulb interneurons are generated from the neural stem cells that are spatially localized in distinct regions of the adult SVZ (Kelsch et al., <xref rid="B39" ref-type="bibr">2007</xref>; Merkle et al., <xref rid="B60" ref-type="bibr">2007</xref>; Young et al., <xref rid="B90" ref-type="bibr">2007</xref>; Brill et al., <xref rid="B9" ref-type="bibr">2009</xref>). Further studies are required to establish whether adult SVZ neural stem cells from spatially distinct regions are limited in their capacity to generate dopaminergic progenitors <italic>in vitro</italic>. In addition to transcription factors, heterogeneous expression of microRNAs may also be instrumental in shaping the <italic>in vitro</italic> potential of adult SVZ neural stem cells to generate dopaminergic neurons (De Chevigny et al., <xref rid="B19" ref-type="bibr">2012</xref>). Further studies are also required to address whether the dopaminergic neurons produced with SVZ-derived progenitors either adopt an olfactory bulb, midbrain or a hybrid dopaminergic phenotype. As discussed above, the olfactory bulb phenotype may be clinically advantageous for replacement cells, but one concern is that olfactory bulb dopaminergic interneurons also co-express of GABA (Kiyokage et al., <xref rid="B42" ref-type="bibr">2010</xref>). The effect of GABA in these potential replacement cells is difficult to predict, but recent studies suggest that nigral dopaminergic neurons inhibit striatal output through the co-release of both dopamine and GABA (Tritsch et al., <xref rid="B83" ref-type="bibr">2012</xref>). Consistent with this observation, about 10% of dopaminergic neurons in substantia nigra pars compacta are reported to co-express mRNA for the GABA biosynthetic enzyme glutamate decarboxylase 65 (Gonzalez-Hernandez et al., <xref rid="B28" ref-type="bibr">2001</xref>). Thus, the co-expressed GABAergic phenotype in olfactory bulb dopaminergic interneurons may be more of a similarity than a difference with nigral dopaminergic neurons. Studies in rodent PD animal models are needed, however, to demonstrate whether the olfactory bulb or a hybrid dopaminergic phenotype can provide functional recovery without producing deleterious side effects.</p>
      </sec>
    </sec>
    <sec sec-type="conclusions" id="s2">
      <title>Conclusions</title>
      <p>The adult SVZ is a promising source of neural stem cells to generate dopaminergic neuronal progenitors for cell transplant strategies in PD. Since these stem cells can be endogenously harvested from patients, they are a potential autologous source of replacement cells. As discussed in this review, however, there are several important technical issues to be addressed in order for adult SVZ neural stem cells to be competitive source for clinically suitable dopaminergic neurons.</p>
      <sec>
        <title>Conflict of interest statement</title>
        <p>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</p>
      </sec>
    </sec>
  </body>
  <back>
    <ref-list>
      <title>References</title>
      <ref id="B1">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Abrous</surname><given-names>N.</given-names></name><name><surname>Guy</surname><given-names>J.</given-names></name><name><surname>Vigny</surname><given-names>A.</given-names></name><name><surname>Calas</surname><given-names>A.</given-names></name><name><surname>Le Moal</surname><given-names>M.</given-names></name><name><surname>Herman</surname><given-names>J. P.</given-names></name></person-group> (<year>1988</year>). <article-title>Development of intracerebral dopaminergic grafts: a combined immunohistochemical and autoradiographic study of its time course and environmental influences</article-title>. <source>J. Comp. Neurol</source>. <volume>273</volume>, <fpage>26</fpage>&#x2013;<lpage>41</lpage>
<pub-id pub-id-type="doi">10.1002/cne.902730104</pub-id><pub-id pub-id-type="pmid">3145292</pub-id></mixed-citation>
      </ref>
      <ref id="B2">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Aguirre</surname><given-names>A.</given-names></name><name><surname>Gallo</surname><given-names>V.</given-names></name></person-group> (<year>2007</year>). <article-title>Reduced EGFR signaling in progenitor cells of the adult subventricular zone attenuates oligodendrogenesis after demyelination</article-title>. <source>Neuron Glia Biol</source>. <volume>3</volume>, <fpage>209</fpage>&#x2013;<lpage>220</lpage>
<pub-id pub-id-type="doi">10.1017/S1740925X08000082</pub-id><pub-id pub-id-type="pmid">18634612</pub-id></mixed-citation>
      </ref>
      <ref id="B3">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Andereggen</surname><given-names>L.</given-names></name><name><surname>Meyer</surname><given-names>M.</given-names></name><name><surname>Guzman</surname><given-names>R.</given-names></name><name><surname>Ducray</surname><given-names>A. D.</given-names></name><name><surname>Widmer</surname><given-names>H. R.</given-names></name></person-group> (<year>2009</year>). <article-title>Effects of GDNF pretreatment on function and survival of transplanted fetal ventral mesencephalic cells in the 6-OHDA rat model of Parkinson's disease</article-title>. <source>Brain Res</source>. <volume>1276</volume>, <fpage>39</fpage>&#x2013;<lpage>49</lpage>
<pub-id pub-id-type="doi">10.1016/j.brainres.2009.04.021</pub-id><pub-id pub-id-type="pmid">19389387</pub-id></mixed-citation>
      </ref>
      <ref id="B4">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Andersson</surname><given-names>E.</given-names></name><name><surname>Tryggvason</surname><given-names>U.</given-names></name><name><surname>Deng</surname><given-names>Q.</given-names></name><name><surname>Friling</surname><given-names>S.</given-names></name><name><surname>Alekseenko</surname><given-names>Z.</given-names></name><name><surname>Robert</surname><given-names>B.</given-names></name><etal/></person-group> (<year>2006</year>). <article-title>Identification of intrinsic determinants of midbrain dopamine neurons</article-title>. <source>Cell</source>
<volume>124</volume>, <fpage>393</fpage>&#x2013;<lpage>405</lpage>
<pub-id pub-id-type="doi">10.1016/j.cell.2005.10.037</pub-id><pub-id pub-id-type="pmid">16439212</pub-id></mixed-citation>
      </ref>
      <ref id="B5">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Apostolides</surname><given-names>C.</given-names></name><name><surname>Sanford</surname><given-names>E.</given-names></name><name><surname>Hong</surname><given-names>M.</given-names></name><name><surname>Mendez</surname><given-names>I.</given-names></name></person-group> (<year>1998</year>). <article-title>Glial cell line-derived neurotrophic factor improves intrastriatal graft survival of stored dopaminergic cells</article-title>. <source>Neuroscience</source>
<volume>83</volume>, <fpage>363</fpage>&#x2013;<lpage>372</lpage>
<pub-id pub-id-type="doi">10.1016/S0306-4522(97)00369-2</pub-id><pub-id pub-id-type="pmid">9460746</pub-id></mixed-citation>
      </ref>
      <ref id="B6">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bjorklund</surname><given-names>L. M.</given-names></name><name><surname>Sanchez-Pernaute</surname><given-names>R.</given-names></name><name><surname>Chung</surname><given-names>S.</given-names></name><name><surname>Andersson</surname><given-names>T.</given-names></name><name><surname>Chen</surname><given-names>I. Y.</given-names></name><name><surname>Mcnaught</surname><given-names>K. S.</given-names></name><etal/></person-group> (<year>2002</year>). <article-title>Embryonic stem cells develop into functional dopaminergic neurons after transplantation in a Parkinson rat model</article-title>. <source>Proc. Natl. Acad. Sci. U.S.A</source>. <volume>99</volume>, <fpage>2344</fpage>&#x2013;<lpage>2349</lpage>
<pub-id pub-id-type="doi">10.1073/pnas.022438099</pub-id><pub-id pub-id-type="pmid">11782534</pub-id></mixed-citation>
      </ref>
      <ref id="B7">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Boyer</surname><given-names>L. F.</given-names></name><name><surname>Campbell</surname><given-names>B.</given-names></name><name><surname>Larkin</surname><given-names>S.</given-names></name><name><surname>Mu</surname><given-names>Y.</given-names></name><name><surname>Gage</surname><given-names>F. H.</given-names></name></person-group> (<year>2012</year>). <article-title>Dopaminergic differentiation of human pluripotent cells</article-title>. <source>Curr. Protoc. Stem Cell Biol</source>. Chapter 1:Unit1H.6. <pub-id pub-id-type="doi">10.1002/9780470151808.sc01h06s22</pub-id><pub-id pub-id-type="pmid">22872424</pub-id></mixed-citation>
      </ref>
      <ref id="B8">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Braak</surname><given-names>H.</given-names></name><name><surname>Ghebremedhin</surname><given-names>E.</given-names></name><name><surname>Rub</surname><given-names>U.</given-names></name><name><surname>Bratzke</surname><given-names>H.</given-names></name><name><surname>Del Tredici</surname><given-names>K.</given-names></name></person-group> (<year>2004</year>). <article-title>Stages in the development of Parkinson's disease-related pathology</article-title>. <source>Cell Tissue Res</source>. <volume>318</volume>, <fpage>121</fpage>&#x2013;<lpage>134</lpage>
<pub-id pub-id-type="doi">10.1007/s00441-004-0956-9</pub-id><pub-id pub-id-type="pmid">15338272</pub-id></mixed-citation>
      </ref>
      <ref id="B9">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Brill</surname><given-names>M. S.</given-names></name><name><surname>Ninkovic</surname><given-names>J.</given-names></name><name><surname>Winpenny</surname><given-names>E.</given-names></name><name><surname>Hodge</surname><given-names>R. D.</given-names></name><name><surname>Ozen</surname><given-names>I.</given-names></name><name><surname>Yang</surname><given-names>R.</given-names></name><etal/></person-group> (<year>2009</year>). <article-title>Adult generation of glutamatergic olfactory bulb interneurons</article-title>. <source>Nat. Neurosci</source>. <volume>12</volume>, <fpage>1524</fpage>&#x2013;<lpage>1533</lpage>
<pub-id pub-id-type="doi">10.1038/nn.2416</pub-id><pub-id pub-id-type="pmid">19881504</pub-id></mixed-citation>
      </ref>
      <ref id="B10">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Carlsson</surname><given-names>T.</given-names></name><name><surname>Carta</surname><given-names>M.</given-names></name><name><surname>Winkler</surname><given-names>C.</given-names></name><name><surname>Bjorklund</surname><given-names>A.</given-names></name><name><surname>Kirik</surname><given-names>D.</given-names></name></person-group> (<year>2007</year>). <article-title>Serotonin neuron transplants exacerbate L-DOPA-induced dyskinesias in a rat model of Parkinson's disease</article-title>. <source>J. Neurosci</source>. <volume>27</volume>, <fpage>8011</fpage>&#x2013;<lpage>8022</lpage>
<pub-id pub-id-type="doi">10.1523/JNEUROSCI.2079-07.2007</pub-id><pub-id pub-id-type="pmid">17652591</pub-id></mixed-citation>
      </ref>
      <ref id="B11">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Carlsson</surname><given-names>T.</given-names></name><name><surname>Winkler</surname><given-names>C.</given-names></name><name><surname>Lundblad</surname><given-names>M.</given-names></name><name><surname>Cenci</surname><given-names>M. A.</given-names></name><name><surname>Bjorklund</surname><given-names>A.</given-names></name><name><surname>Kirik</surname><given-names>D.</given-names></name></person-group> (<year>2006</year>). <article-title>Graft placement and uneven pattern of reinnervation in the striatum is important for development of graft-induced dyskinesia</article-title>. <source>Neurobiol. Dis</source>. <volume>21</volume>, <fpage>657</fpage>&#x2013;<lpage>668</lpage>
<pub-id pub-id-type="doi">10.1016/j.nbd.2005.09.008</pub-id><pub-id pub-id-type="pmid">16256359</pub-id></mixed-citation>
      </ref>
      <ref id="B12">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cave</surname><given-names>J. W.</given-names></name><name><surname>Baker</surname><given-names>H.</given-names></name></person-group> (<year>2009</year>). <article-title>Dopamine systems in the forebrain</article-title>. <source>Adv. Exp. Med. Biol</source>. <volume>651</volume>, <fpage>15</fpage>&#x2013;<lpage>35</lpage>
<pub-id pub-id-type="doi">10.1007/978-1-4419-0322-8_2</pub-id><pub-id pub-id-type="pmid">19731547</pub-id></mixed-citation>
      </ref>
      <ref id="B13">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chang</surname><given-names>Y. L.</given-names></name><name><surname>Chen</surname><given-names>S. J.</given-names></name><name><surname>Kao</surname><given-names>C. L.</given-names></name><name><surname>Hung</surname><given-names>S. C.</given-names></name><name><surname>Ding</surname><given-names>D. C.</given-names></name><name><surname>Yu</surname><given-names>C. C.</given-names></name><etal/></person-group> (<year>2012</year>). <article-title>Docosahexaenoic acid promotes dopaminergic differentiation in induced pluripotent stem cells and inhibits teratoma formation in rats with Parkinson-like pathology</article-title>. <source>Cell Transplant</source>. <volume>21</volume>, <fpage>313</fpage>&#x2013;<lpage>332</lpage>
<pub-id pub-id-type="doi">10.3727/096368911X580572</pub-id><pub-id pub-id-type="pmid">21669041</pub-id></mixed-citation>
      </ref>
      <ref id="B14">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>K.</given-names></name><name><surname>Henry</surname><given-names>R. A.</given-names></name><name><surname>Hughes</surname><given-names>S. M.</given-names></name><name><surname>Connor</surname><given-names>B.</given-names></name></person-group> (<year>2007a</year>). <article-title>Creating a neurogenic environment: the role of BDNF and FGF2</article-title>. <source>Mol. Cell. Neurosci</source>. <volume>36</volume>, <fpage>108</fpage>&#x2013;<lpage>120</lpage>
<pub-id pub-id-type="doi">10.1016/j.mcn.2007.06.004</pub-id><pub-id pub-id-type="pmid">17656107</pub-id></mixed-citation>
      </ref>
      <ref id="B15">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>K.</given-names></name><name><surname>Hughes</surname><given-names>S. M.</given-names></name><name><surname>Connor</surname><given-names>B.</given-names></name></person-group> (<year>2007b</year>). <article-title>Neural progenitor cells derived from the adult rat subventricular zone: characterization and transplantation</article-title>. <source>Cell Transplant</source>. <volume>16</volume>, <fpage>799</fpage>&#x2013;<lpage>810</lpage>
<pub-id pub-id-type="doi">10.3727/000000007783465253</pub-id><pub-id pub-id-type="pmid">18088000</pub-id></mixed-citation>
      </ref>
      <ref id="B16">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cho</surname><given-names>M. S.</given-names></name><name><surname>Lee</surname><given-names>Y. E.</given-names></name><name><surname>Kim</surname><given-names>J. Y.</given-names></name><name><surname>Chung</surname><given-names>S.</given-names></name><name><surname>Cho</surname><given-names>Y. H.</given-names></name><name><surname>Kim</surname><given-names>D. S.</given-names></name><etal/></person-group> (<year>2008</year>). <article-title>Highly efficient and large-scale generation of functional dopamine neurons from human embryonic stem cells</article-title>. <source>Proc. Natl. Acad. Sci. U.S.A</source>. <volume>105</volume>, <fpage>3392</fpage>&#x2013;<lpage>3397</lpage>
<pub-id pub-id-type="doi">10.1073/pnas.0712359105</pub-id><pub-id pub-id-type="pmid">18305158</pub-id></mixed-citation>
      </ref>
      <ref id="B17">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chung</surname><given-names>S.</given-names></name><name><surname>Hedlund</surname><given-names>E.</given-names></name><name><surname>Hwang</surname><given-names>M.</given-names></name><name><surname>Kim</surname><given-names>D. W.</given-names></name><name><surname>Shin</surname><given-names>B. S.</given-names></name><name><surname>Hwang</surname><given-names>D. Y.</given-names></name><etal/></person-group> (<year>2005</year>). <article-title>The homeodomain transcription factor Pitx3 facilitates differentiation of mouse embryonic stem cells into AHD2-expressing dopaminergic neurons</article-title>. <source>Mol. Cell. Neurosci</source>. <volume>28</volume>, <fpage>241</fpage>&#x2013;<lpage>252</lpage>
<pub-id pub-id-type="doi">10.1016/j.mcn.2004.09.008</pub-id><pub-id pub-id-type="pmid">15691706</pub-id></mixed-citation>
      </ref>
      <ref id="B18">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chung</surname><given-names>S.</given-names></name><name><surname>Sonntag</surname><given-names>K. C.</given-names></name><name><surname>Andersson</surname><given-names>T.</given-names></name><name><surname>Bjorklund</surname><given-names>L. M.</given-names></name><name><surname>Park</surname><given-names>J. J.</given-names></name><name><surname>Kim</surname><given-names>D. W.</given-names></name><etal/></person-group> (<year>2002</year>). <article-title>Genetic engineering of mouse embryonic stem cells by Nurr1 enhances differentiation and maturation into dopaminergic neurons</article-title>. <source>Eur. J. Neurosci</source>. <volume>16</volume>, <fpage>1829</fpage>&#x2013;<lpage>1838</lpage>
<pub-id pub-id-type="doi">10.1046/j.1460-9568.2002.02255.x</pub-id><pub-id pub-id-type="pmid">12453046</pub-id></mixed-citation>
      </ref>
      <ref id="B19">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>De Chevigny</surname><given-names>A.</given-names></name><name><surname>Core</surname><given-names>N.</given-names></name><name><surname>Follert</surname><given-names>P.</given-names></name><name><surname>Gaudin</surname><given-names>M.</given-names></name><name><surname>Barbry</surname><given-names>P.</given-names></name><name><surname>Beclin</surname><given-names>C.</given-names></name><etal/></person-group> (<year>2012</year>). <article-title>miR-7a regulation of Pax6 controls spatial origin of forebrain dopaminergic neurons</article-title>. <source>Nat. Neurosci</source>. <volume>15</volume>, <fpage>1120</fpage>&#x2013;<lpage>1126</lpage>
<pub-id pub-id-type="doi">10.1038/nn.3142</pub-id><pub-id pub-id-type="pmid">22729175</pub-id></mixed-citation>
      </ref>
      <ref id="B20">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Defer</surname><given-names>G. L.</given-names></name><name><surname>Geny</surname><given-names>C.</given-names></name><name><surname>Ricolfi</surname><given-names>F.</given-names></name><name><surname>Fenelon</surname><given-names>G.</given-names></name><name><surname>Monfort</surname><given-names>J. C.</given-names></name><name><surname>Remy</surname><given-names>P.</given-names></name><etal/></person-group> (<year>1996</year>). <article-title>Long-term outcome of unilaterally transplanted parkinsonian patients. I. Clinical approach</article-title>. <source>Brain</source>
<volume>119</volume>(<issue>Pt 1</issue>), <fpage>41</fpage>&#x2013;<lpage>50</lpage>
<pub-id pub-id-type="doi">10.1093/brain/119.1.41</pub-id><pub-id pub-id-type="pmid">8624693</pub-id></mixed-citation>
      </ref>
      <ref id="B21">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Deleidi</surname><given-names>M.</given-names></name><name><surname>Cooper</surname><given-names>O.</given-names></name><name><surname>Hargus</surname><given-names>G.</given-names></name><name><surname>Levy</surname><given-names>A.</given-names></name><name><surname>Isacson</surname><given-names>O.</given-names></name></person-group> (<year>2011</year>). <article-title>Oct4-induced reprogramming is required for adult brain neural stem cell differentiation into midbrain dopaminergic neurons</article-title>. <source>PLoS ONE</source>
<volume>6</volume>:<fpage>e19926</fpage>
<pub-id pub-id-type="doi">10.1371/journal.pone.0019926</pub-id><pub-id pub-id-type="pmid">21655272</pub-id></mixed-citation>
      </ref>
      <ref id="B22">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Deleyrolle</surname><given-names>L. P.</given-names></name><name><surname>Reynolds</surname><given-names>B. A.</given-names></name></person-group> (<year>2009</year>). <article-title>Isolation, expansion, and differentiation of adult Mammalian neural stem and progenitor cells using the neurosphere assay</article-title>. <source>Methods Mol. Biol</source>. <volume>549</volume>, <fpage>91</fpage>&#x2013;<lpage>101</lpage>
<pub-id pub-id-type="doi">10.1007/978-1-60327-931-4_7</pub-id><pub-id pub-id-type="pmid">19378198</pub-id></mixed-citation>
      </ref>
      <ref id="B23">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Espejo</surname><given-names>M.</given-names></name><name><surname>Cutillas</surname><given-names>B.</given-names></name><name><surname>Arenas</surname><given-names>T. E.</given-names></name><name><surname>Ambrosio</surname><given-names>S.</given-names></name></person-group> (<year>2000</year>). <article-title>Increased survival of dopaminergic neurons in striatal grafts of fetal ventral mesencephalic cells exposed to neurotrophin-3 or glial cell line-derived neurotrophic factor</article-title>. <source>Cell Transplant</source>. <volume>9</volume>, <fpage>45</fpage>&#x2013;<lpage>53</lpage>
<pub-id pub-id-type="pmid">10784066</pub-id></mixed-citation>
      </ref>
      <ref id="B24">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Freed</surname><given-names>C. R.</given-names></name><name><surname>Greene</surname><given-names>P. E.</given-names></name><name><surname>Breeze</surname><given-names>R. E.</given-names></name><name><surname>Tsai</surname><given-names>W. Y.</given-names></name><name><surname>Dumouchel</surname><given-names>W.</given-names></name><name><surname>Kao</surname><given-names>R.</given-names></name><etal/></person-group> (<year>2001</year>). <article-title>Transplantation of embryonic dopamine neurons for severe Parkinson's disease</article-title>. <source>N. Engl. J. Med</source>. <volume>344</volume>, <fpage>710</fpage>&#x2013;<lpage>719</lpage>
<pub-id pub-id-type="doi">10.1056/NEJM200103083441002</pub-id><pub-id pub-id-type="pmid">11236774</pub-id></mixed-citation>
      </ref>
      <ref id="B25">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Friling</surname><given-names>S.</given-names></name><name><surname>Andersson</surname><given-names>E.</given-names></name><name><surname>Thompson</surname><given-names>L. H.</given-names></name><name><surname>Jonsson</surname><given-names>M. E.</given-names></name><name><surname>Hebsgaard</surname><given-names>J. B.</given-names></name><name><surname>Nanou</surname><given-names>E.</given-names></name><etal/></person-group> (<year>2009</year>). <article-title>Efficient production of mesencephalic dopamine neurons by Lmx1a expression in embryonic stem cells</article-title>. <source>Proc. Natl. Acad. Sci. U.S.A</source>. <volume>106</volume>, <fpage>7613</fpage>&#x2013;<lpage>7618</lpage>
<pub-id pub-id-type="doi">10.1073/pnas.0902396106</pub-id><pub-id pub-id-type="pmid">19383789</pub-id></mixed-citation>
      </ref>
      <ref id="B26">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Frodl</surname><given-names>E. M.</given-names></name><name><surname>Duan</surname><given-names>W. M.</given-names></name><name><surname>Sauer</surname><given-names>H.</given-names></name><name><surname>Kupsch</surname><given-names>A.</given-names></name><name><surname>Brundin</surname><given-names>P.</given-names></name></person-group> (<year>1994</year>). <article-title>Human embryonic dopamine neurons xenografted to the rat: effects of cryopreservation and varying regional source of donor cells on transplant survival, morphology and function</article-title>. <source>Brain Res</source>. <volume>647</volume>, <fpage>286</fpage>&#x2013;<lpage>298</lpage>
<pub-id pub-id-type="doi">10.1016/0006-8993(94)91328-5</pub-id><pub-id pub-id-type="pmid">7922505</pub-id></mixed-citation>
      </ref>
      <ref id="B27">
        <mixed-citation publication-type="book"><person-group person-group-type="author"><name><surname>Gage</surname><given-names>F. H.</given-names></name><name><surname>Kempermann</surname><given-names>G.</given-names></name><name><surname>Song</surname><given-names>H.</given-names></name></person-group> (<year>2008</year>). <source>Adult Neurogenesis</source>. <publisher-loc>Cold Spring Harbor, NY</publisher-loc>: <publisher-name>Cold Spring Harbor Laboratory Press</publisher-name></mixed-citation>
      </ref>
      <ref id="B28">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gonzalez-Hernandez</surname><given-names>T.</given-names></name><name><surname>Barroso-Chinea</surname><given-names>P.</given-names></name><name><surname>Acevedo</surname><given-names>A.</given-names></name><name><surname>Salido</surname><given-names>E.</given-names></name><name><surname>Rodriguez</surname><given-names>M.</given-names></name></person-group> (<year>2001</year>). <article-title>Colocalization of tyrosine hydroxylase and GAD65 mRNA in mesostriatal neurons</article-title>. <source>Eur. J. Neurosci</source>. <volume>13</volume>, <fpage>57</fpage>&#x2013;<lpage>67</lpage>
<pub-id pub-id-type="doi">10.1111/j.1460-9568.2001.01371.x</pub-id><pub-id pub-id-type="pmid">11135004</pub-id></mixed-citation>
      </ref>
      <ref id="B29">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gonzalez-Perez</surname><given-names>O.</given-names></name><name><surname>Alvarez-Buylla</surname><given-names>A.</given-names></name></person-group> (<year>2011</year>). <article-title>Oligodendrogenesis in the subventricular zone and the role of epidermal growth factor</article-title>. <source>Brain Res. Rev</source>. <volume>67</volume>, <fpage>147</fpage>&#x2013;<lpage>156</lpage>
<pub-id pub-id-type="doi">10.1016/j.brainresrev.2011.01.001</pub-id><pub-id pub-id-type="pmid">21236296</pub-id></mixed-citation>
      </ref>
      <ref id="B30">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gonzalez-Perez</surname><given-names>O.</given-names></name><name><surname>Quinones-Hinojosa</surname><given-names>A.</given-names></name></person-group> (<year>2010</year>). <article-title>Dose-dependent effect of EGF on migration and differentiation of adult subventricular zone astrocytes</article-title>. <source>Glia</source>
<volume>58</volume>, <fpage>975</fpage>&#x2013;<lpage>983</lpage>
<pub-id pub-id-type="doi">10.1002/glia.20979</pub-id><pub-id pub-id-type="pmid">20187143</pub-id></mixed-citation>
      </ref>
      <ref id="B31">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gritti</surname><given-names>A.</given-names></name><name><surname>Dal Molin</surname><given-names>M.</given-names></name><name><surname>Foroni</surname><given-names>C.</given-names></name><name><surname>Bonfanti</surname><given-names>L.</given-names></name></person-group> (<year>2009</year>). <article-title>Effects of developmental age, brain region, and time in culture on long-term proliferation and multipotency of neural stem cell populations</article-title>. <source>J. Comp. Neurol</source>. <volume>517</volume>, <fpage>333</fpage>&#x2013;<lpage>349</lpage>
<pub-id pub-id-type="doi">10.1002/cne.22153</pub-id><pub-id pub-id-type="pmid">19760739</pub-id></mixed-citation>
      </ref>
      <ref id="B32">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Guzman</surname><given-names>J. N.</given-names></name><name><surname>Sanchez-Padilla</surname><given-names>J.</given-names></name><name><surname>Chan</surname><given-names>C. S.</given-names></name><name><surname>Surmeier</surname><given-names>D. J.</given-names></name></person-group> (<year>2009</year>). <article-title>Robust pacemaking in substantia nigra dopaminergic neurons</article-title>. <source>J. Neurosci</source>. <volume>29</volume>, <fpage>11011</fpage>&#x2013;<lpage>11019</lpage>
<pub-id pub-id-type="doi">10.1523/JNEUROSCI.2519-09.2009</pub-id><pub-id pub-id-type="pmid">19726659</pub-id></mixed-citation>
      </ref>
      <ref id="B33">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hagell</surname><given-names>P.</given-names></name><name><surname>Brundin</surname><given-names>P.</given-names></name></person-group> (<year>2001</year>). <article-title>Cell survival and clinical outcome following intrastriatal transplantation in Parkinson disease</article-title>. <source>J. Neuropathol. Exp. Neurol</source>. <volume>60</volume>, <fpage>741</fpage>&#x2013;<lpage>752</lpage>
<pub-id pub-id-type="pmid">11487048</pub-id></mixed-citation>
      </ref>
      <ref id="B34">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hargus</surname><given-names>G.</given-names></name><name><surname>Cooper</surname><given-names>O.</given-names></name><name><surname>Deleidi</surname><given-names>M.</given-names></name><name><surname>Levy</surname><given-names>A.</given-names></name><name><surname>Lee</surname><given-names>K.</given-names></name><name><surname>Marlow</surname><given-names>E.</given-names></name><etal/></person-group> (<year>2010</year>). <article-title>Differentiated Parkinson patient-derived induced pluripotent stem cells grow in the adult rodent brain and reduce motor asymmetry in Parkinsonian rats</article-title>. <source>Proc. Natl. Acad. Sci. U.S.A</source>. <volume>107</volume>, <fpage>15921</fpage>&#x2013;<lpage>15926</lpage>
<pub-id pub-id-type="doi">10.1073/pnas.1010209107</pub-id><pub-id pub-id-type="pmid">20798034</pub-id></mixed-citation>
      </ref>
      <ref id="B35">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Herrera</surname><given-names>D. G.</given-names></name><name><surname>Garcia-Verdugo</surname><given-names>J. M.</given-names></name><name><surname>Alvarez-Buylla</surname><given-names>A.</given-names></name></person-group> (<year>1999</year>). <article-title>Adult-derived neural precursors transplanted into multiple regions in the adult brain</article-title>. <source>Ann. Neurol</source>. <volume>46</volume>, <fpage>867</fpage>&#x2013;<lpage>877</lpage>
<pub-id pub-id-type="doi">10.1002/1531-8249(199912)46:6%3C867::AID-ANA9%3E3.0.CO;2-Z</pub-id><pub-id pub-id-type="pmid">10589539</pub-id></mixed-citation>
      </ref>
      <ref id="B36">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hoglinger</surname><given-names>G. U.</given-names></name><name><surname>Widmer</surname><given-names>H. R.</given-names></name><name><surname>Spenger</surname><given-names>C.</given-names></name><name><surname>Meyer</surname><given-names>M.</given-names></name><name><surname>Seiler</surname><given-names>R. W.</given-names></name><name><surname>Oertel</surname><given-names>W. H.</given-names></name><etal/></person-group> (<year>2001</year>). <article-title>Influence of time in culture and BDNF pretreatment on survival and function of grafted embryonic rat ventral mesencephalon in the 6-OHDA rat model of Parkinson's disease</article-title>. <source>Exp. Neurol</source>. <volume>167</volume>, <fpage>148</fpage>&#x2013;<lpage>157</lpage>
<pub-id pub-id-type="doi">10.1006/exnr.2000.7546</pub-id><pub-id pub-id-type="pmid">11161602</pub-id></mixed-citation>
      </ref>
      <ref id="B37">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Huisman</surname><given-names>E.</given-names></name><name><surname>Uylings</surname><given-names>H. B.</given-names></name><name><surname>Hoogland</surname><given-names>P. V.</given-names></name></person-group> (<year>2004</year>). <article-title>A 100% increase of dopaminergic cells in the olfactory bulb may explain hyposmia in Parkinson's disease</article-title>. <source>Mov. Disord</source>. <volume>19</volume>, <fpage>687</fpage>&#x2013;<lpage>692</lpage>
<pub-id pub-id-type="doi">10.1002/mds.10713</pub-id><pub-id pub-id-type="pmid">15197709</pub-id></mixed-citation>
      </ref>
      <ref id="B38">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ihrie</surname><given-names>R. A.</given-names></name><name><surname>Alvarez-Buylla</surname><given-names>A.</given-names></name></person-group> (<year>2011</year>). <article-title>Lake-front property: a unique germinal niche by the lateral ventricles of the adult brain</article-title>. <source>Neuron</source>
<volume>70</volume>, <fpage>674</fpage>&#x2013;<lpage>686</lpage>
<pub-id pub-id-type="doi">10.1016/j.neuron.2011.05.004</pub-id><pub-id pub-id-type="pmid">21609824</pub-id></mixed-citation>
      </ref>
      <ref id="B39">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kelsch</surname><given-names>W.</given-names></name><name><surname>Mosley</surname><given-names>C. P.</given-names></name><name><surname>Lin</surname><given-names>C. W.</given-names></name><name><surname>Lois</surname><given-names>C.</given-names></name></person-group> (<year>2007</year>). <article-title>Distinct mammalian precursors are committed to generate neurons with defined dendritic projection patterns</article-title>. <source>PLoS Biol</source>. <volume>5</volume>:<fpage>e300</fpage>
<pub-id pub-id-type="doi">10.1371/journal.pbio.0050300</pub-id><pub-id pub-id-type="pmid">18001150</pub-id></mixed-citation>
      </ref>
      <ref id="B40">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kim</surname><given-names>J. B.</given-names></name><name><surname>Sebastiano</surname><given-names>V.</given-names></name><name><surname>Wu</surname><given-names>G.</given-names></name><name><surname>Arauzo-Bravo</surname><given-names>M. J.</given-names></name><name><surname>Sasse</surname><given-names>P.</given-names></name><name><surname>Gentile</surname><given-names>L.</given-names></name><etal/></person-group> (<year>2009</year>). <article-title>Oct4-induced pluripotency in adult neural stem cells</article-title>. <source>Cell</source>
<volume>136</volume>, <fpage>411</fpage>&#x2013;<lpage>419</lpage>
<pub-id pub-id-type="doi">10.1016/j.cell.2009.01.023</pub-id><pub-id pub-id-type="pmid">19203577</pub-id></mixed-citation>
      </ref>
      <ref id="B41">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kim</surname><given-names>J. H.</given-names></name><name><surname>Auerbach</surname><given-names>J. M.</given-names></name><name><surname>Rodriguez-Gomez</surname><given-names>J. A.</given-names></name><name><surname>Velasco</surname><given-names>I.</given-names></name><name><surname>Gavin</surname><given-names>D.</given-names></name><name><surname>Lumelsky</surname><given-names>N.</given-names></name><etal/></person-group> (<year>2002</year>). <article-title>Dopamine neurons derived from embryonic stem cells function in an animal model of Parkinson's disease</article-title>. <source>Nature</source>
<volume>418</volume>, <fpage>50</fpage>&#x2013;<lpage>56</lpage>
<pub-id pub-id-type="doi">10.1038/nature00900</pub-id><pub-id pub-id-type="pmid">12077607</pub-id></mixed-citation>
      </ref>
      <ref id="B42">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kiyokage</surname><given-names>E.</given-names></name><name><surname>Pan</surname><given-names>Y. Z.</given-names></name><name><surname>Shao</surname><given-names>Z.</given-names></name><name><surname>Kobayashi</surname><given-names>K.</given-names></name><name><surname>Szabo</surname><given-names>G.</given-names></name><name><surname>Yanagawa</surname><given-names>Y.</given-names></name><etal/></person-group> (<year>2010</year>). <article-title>Molecular identity of periglomerular and short axon cells</article-title>. <source>J. Neurosci</source>. <volume>30</volume>, <fpage>1185</fpage>&#x2013;<lpage>1196</lpage>
<pub-id pub-id-type="doi">10.1523/JNEUROSCI.3497-09.2010</pub-id><pub-id pub-id-type="pmid">20089927</pub-id></mixed-citation>
      </ref>
      <ref id="B43">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kordower</surname><given-names>J. H.</given-names></name><name><surname>Chu</surname><given-names>Y.</given-names></name><name><surname>Hauser</surname><given-names>R. A.</given-names></name><name><surname>Freeman</surname><given-names>T. B.</given-names></name><name><surname>Olanow</surname><given-names>C. W.</given-names></name></person-group> (<year>2008a</year>). <article-title>Lewy body-like pathology in long-term embryonic nigral transplants in Parkinson's disease</article-title>. <source>Nat. Med</source>. <volume>14</volume>, <fpage>504</fpage>&#x2013;<lpage>506</lpage>
<pub-id pub-id-type="doi">10.1038/nm1747</pub-id><pub-id pub-id-type="pmid">18391962</pub-id></mixed-citation>
      </ref>
      <ref id="B44">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kordower</surname><given-names>J. H.</given-names></name><name><surname>Chu</surname><given-names>Y.</given-names></name><name><surname>Hauser</surname><given-names>R. A.</given-names></name><name><surname>Olanow</surname><given-names>C. W.</given-names></name><name><surname>Freeman</surname><given-names>T. B.</given-names></name></person-group> (<year>2008b</year>). <article-title>Transplanted dopaminergic neurons develop PD pathologic changes: a second case report</article-title>. <source>Mov. Disord</source>. <volume>23</volume>, <fpage>2303</fpage>&#x2013;<lpage>2306</lpage>
<pub-id pub-id-type="doi">10.1002/mds.22369</pub-id><pub-id pub-id-type="pmid">19006193</pub-id></mixed-citation>
      </ref>
      <ref id="B45">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kriks</surname><given-names>S.</given-names></name><name><surname>Studer</surname><given-names>L.</given-names></name></person-group> (<year>2009</year>). <article-title>Protocols for generating ES cell-derived dopamine neurons</article-title>. <source>Adv. Exp. Med. Biol</source>. <volume>651</volume>, <fpage>101</fpage>&#x2013;<lpage>111</lpage>
<pub-id pub-id-type="doi">10.1007/978-1-4419-0322-8_10</pub-id><pub-id pub-id-type="pmid">19731555</pub-id></mixed-citation>
      </ref>
      <ref id="B46">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>J. Y.</given-names></name><name><surname>Englund</surname><given-names>E.</given-names></name><name><surname>Holton</surname><given-names>J. L.</given-names></name><name><surname>Soulet</surname><given-names>D.</given-names></name><name><surname>Hagell</surname><given-names>P.</given-names></name><name><surname>Lees</surname><given-names>A. J.</given-names></name><etal/></person-group> (<year>2008</year>). <article-title>Lewy bodies in grafted neurons in subjects with Parkinson's disease suggest host-to-graft disease propagation</article-title>. <source>Nat. Med</source>. <volume>14</volume>, <fpage>501</fpage>&#x2013;<lpage>503</lpage>
<pub-id pub-id-type="doi">10.1038/nm1746</pub-id><pub-id pub-id-type="pmid">18391963</pub-id></mixed-citation>
      </ref>
      <ref id="B47">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>J. Y.</given-names></name><name><surname>Englund</surname><given-names>E.</given-names></name><name><surname>Widner</surname><given-names>H.</given-names></name><name><surname>Rehncrona</surname><given-names>S.</given-names></name><name><surname>Bjorklund</surname><given-names>A.</given-names></name><name><surname>Lindvall</surname><given-names>O.</given-names></name><etal/></person-group> (<year>2010</year>). <article-title>Characterization of Lewy body pathology in 12- and 16-year-old intrastriatal mesencephalic grafts surviving in a patient with Parkinson's disease</article-title>. <source>Mov. Disord</source>. <volume>25</volume>, <fpage>1091</fpage>&#x2013;<lpage>1096</lpage>
<pub-id pub-id-type="doi">10.1002/mds.23012</pub-id><pub-id pub-id-type="pmid">20198645</pub-id></mixed-citation>
      </ref>
      <ref id="B48">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lim</surname><given-names>D. A.</given-names></name><name><surname>Tramontin</surname><given-names>A. D.</given-names></name><name><surname>Trevejo</surname><given-names>J. M.</given-names></name><name><surname>Herrera</surname><given-names>D. G.</given-names></name><name><surname>Garcia-Verdugo</surname><given-names>J. M.</given-names></name><name><surname>Alvarez-Buylla</surname><given-names>A.</given-names></name></person-group> (<year>2000</year>). <article-title>Noggin antagonizes BMP signaling to create a niche for adult neurogenesis</article-title>. <source>Neuron</source>
<volume>28</volume>, <fpage>713</fpage>&#x2013;<lpage>726</lpage>
<pub-id pub-id-type="doi">10.1016/S0896-6273(00)00148-3</pub-id><pub-id pub-id-type="pmid">11163261</pub-id></mixed-citation>
      </ref>
      <ref id="B49">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lindvall</surname><given-names>O.</given-names></name><name><surname>Bjorklund</surname><given-names>A.</given-names></name></person-group> (<year>2011</year>). <article-title>Cell therapeutics in Parkinson's disease</article-title>. <source>Neurotherapeutics</source>
<volume>8</volume>, <fpage>539</fpage>&#x2013;<lpage>548</lpage>
<pub-id pub-id-type="doi">10.1007/s13311-011-0069-6</pub-id><pub-id pub-id-type="pmid">21901584</pub-id></mixed-citation>
      </ref>
      <ref id="B50">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lois</surname><given-names>C.</given-names></name><name><surname>Alvarez-Buylla</surname><given-names>A.</given-names></name></person-group> (<year>1994</year>). <article-title>Long-distance neuronal migration in the adult mammalian brain</article-title>. <source>Science</source>
<volume>264</volume>, <fpage>1145</fpage>&#x2013;<lpage>1148</lpage>
<pub-id pub-id-type="doi">10.1126/science.8178174</pub-id><pub-id pub-id-type="pmid">8178174</pub-id></mixed-citation>
      </ref>
      <ref id="B51">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lowry</surname><given-names>W. E.</given-names></name><name><surname>Plath</surname><given-names>K.</given-names></name></person-group> (<year>2008</year>). <article-title>The many ways to make an iPS cell</article-title>. <source>Nat. Biotechnol</source>. <volume>26</volume>, <fpage>1246</fpage>&#x2013;<lpage>1248</lpage>
<pub-id pub-id-type="doi">10.1038/nbt1108-1246</pub-id><pub-id pub-id-type="pmid">18997764</pub-id></mixed-citation>
      </ref>
      <ref id="B52">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lum</surname><given-names>M.</given-names></name><name><surname>Turbic</surname><given-names>A.</given-names></name><name><surname>Mitrovic</surname><given-names>B.</given-names></name><name><surname>Turnley</surname><given-names>A. M.</given-names></name></person-group> (<year>2009</year>). <article-title>Fibroblast growth factor-9 inhibits astrocyte differentiation of adult mouse neural progenitor cells</article-title>. <source>J. Neurosci. Res</source>. <volume>87</volume>, <fpage>2201</fpage>&#x2013;<lpage>2210</lpage>
<pub-id pub-id-type="doi">10.1002/jnr.22047</pub-id><pub-id pub-id-type="pmid">19267409</pub-id></mixed-citation>
      </ref>
      <ref id="B53">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Luskin</surname><given-names>M. B.</given-names></name></person-group> (<year>1993</year>). <article-title>Restricted proliferation and migration of postnatally generated neurons derived from the forebrain subventricular zone</article-title>. <source>Neuron</source>
<volume>11</volume>, <fpage>173</fpage>&#x2013;<lpage>189</lpage>
<pub-id pub-id-type="doi">10.1016/0896-6273(93)90281-U</pub-id><pub-id pub-id-type="pmid">8338665</pub-id></mixed-citation>
      </ref>
      <ref id="B54">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ma</surname><given-names>Y.</given-names></name><name><surname>Feigin</surname><given-names>A.</given-names></name><name><surname>Dhawan</surname><given-names>V.</given-names></name><name><surname>Fukuda</surname><given-names>M.</given-names></name><name><surname>Shi</surname><given-names>Q.</given-names></name><name><surname>Greene</surname><given-names>P.</given-names></name><etal/></person-group> (<year>2002</year>). <article-title>Dyskinesia after fetal cell transplantation for parkinsonism: a PET study</article-title>. <source>Ann. Neurol</source>. <volume>52</volume>, <fpage>628</fpage>&#x2013;<lpage>634</lpage>
<pub-id pub-id-type="doi">10.1002/ana.10359</pub-id><pub-id pub-id-type="pmid">12402261</pub-id></mixed-citation>
      </ref>
      <ref id="B55">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Maries</surname><given-names>E.</given-names></name><name><surname>Kordower</surname><given-names>J. H.</given-names></name><name><surname>Chu</surname><given-names>Y.</given-names></name><name><surname>Collier</surname><given-names>T. J.</given-names></name><name><surname>Sortwell</surname><given-names>C. E.</given-names></name><name><surname>Olaru</surname><given-names>E.</given-names></name><etal/></person-group> (<year>2006</year>). <article-title>Focal not widespread grafts induce novel dyskinetic behavior in parkinsonian rats</article-title>. <source>Neurobiol. Dis</source>. <volume>21</volume>, <fpage>165</fpage>&#x2013;<lpage>180</lpage>
<pub-id pub-id-type="doi">10.1016/j.nbd.2005.07.002</pub-id><pub-id pub-id-type="pmid">16095907</pub-id></mixed-citation>
      </ref>
      <ref id="B56">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Martinat</surname><given-names>C.</given-names></name><name><surname>Bacci</surname><given-names>J. J.</given-names></name><name><surname>Leete</surname><given-names>T.</given-names></name><name><surname>Kim</surname><given-names>J.</given-names></name><name><surname>Vanti</surname><given-names>W. B.</given-names></name><name><surname>Newman</surname><given-names>A. H.</given-names></name><etal/></person-group> (<year>2006</year>). <article-title>Cooperative transcription activation by Nurr1 and Pitx3 induces embryonic stem cell maturation to the midbrain dopamine neuron phenotype</article-title>. <source>Proc. Natl. Acad. Sci. U.S.A</source>. <volume>103</volume>, <fpage>2874</fpage>&#x2013;<lpage>2879</lpage>
<pub-id pub-id-type="doi">10.1073/pnas.0511153103</pub-id><pub-id pub-id-type="pmid">16477036</pub-id></mixed-citation>
      </ref>
      <ref id="B57">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Meissner</surname><given-names>K. K.</given-names></name><name><surname>Kirkham</surname><given-names>D. L.</given-names></name><name><surname>Doering</surname><given-names>L. C.</given-names></name></person-group> (<year>2005</year>). <article-title>Transplants of neurosphere cell suspensions from aged mice are functional in the mouse model of Parkinson's</article-title>. <source>Brain Res</source>. <volume>1057</volume>, <fpage>105</fpage>&#x2013;<lpage>112</lpage>
<pub-id pub-id-type="doi">10.1016/j.brainres.2005.07.057</pub-id><pub-id pub-id-type="pmid">16140285</pub-id></mixed-citation>
      </ref>
      <ref id="B58">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mendez</surname><given-names>I.</given-names></name><name><surname>Dagher</surname><given-names>A.</given-names></name><name><surname>Hong</surname><given-names>M.</given-names></name><name><surname>Gaudet</surname><given-names>P.</given-names></name><name><surname>Weerasinghe</surname><given-names>S.</given-names></name><name><surname>Mcalister</surname><given-names>V.</given-names></name><etal/></person-group> (<year>2002</year>). <article-title>Simultaneous intrastriatal and intranigral fetal dopaminergic grafts in patients with Parkinson disease: a pilot study. Report of three cases</article-title>. <source>J. Neurosurg</source>. <volume>96</volume>, <fpage>589</fpage>&#x2013;<lpage>596</lpage>
<pub-id pub-id-type="doi">10.3171/jns.2002.96.3.0589</pub-id><pub-id pub-id-type="pmid">11883846</pub-id></mixed-citation>
      </ref>
      <ref id="B59">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mendez</surname><given-names>I.</given-names></name><name><surname>Vinuela</surname><given-names>A.</given-names></name><name><surname>Astradsson</surname><given-names>A.</given-names></name><name><surname>Mukhida</surname><given-names>K.</given-names></name><name><surname>Hallett</surname><given-names>P.</given-names></name><name><surname>Robertson</surname><given-names>H.</given-names></name><etal/></person-group> (<year>2008</year>). <article-title>Dopamine neurons implanted into people with Parkinson's disease survive without pathology for 14 years</article-title>. <source>Nat. Med</source>. <volume>14</volume>, <fpage>507</fpage>&#x2013;<lpage>509</lpage>
<pub-id pub-id-type="doi">10.1038/nm1752</pub-id><pub-id pub-id-type="pmid">18391961</pub-id></mixed-citation>
      </ref>
      <ref id="B60">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Merkle</surname><given-names>F. T.</given-names></name><name><surname>Mirzadeh</surname><given-names>Z.</given-names></name><name><surname>Alvarez-Buylla</surname><given-names>A.</given-names></name></person-group> (<year>2007</year>). <article-title>Mosaic organization of neural stem cells in the adult brain</article-title>. <source>Science</source>
<volume>317</volume>, <fpage>381</fpage>&#x2013;<lpage>384</lpage>
<pub-id pub-id-type="doi">10.1126/science.1144914</pub-id><pub-id pub-id-type="pmid">17615304</pub-id></mixed-citation>
      </ref>
      <ref id="B61">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Meyer</surname><given-names>A. K.</given-names></name><name><surname>Maisel</surname><given-names>M.</given-names></name><name><surname>Hermann</surname><given-names>A.</given-names></name><name><surname>Stirl</surname><given-names>K.</given-names></name><name><surname>Storch</surname><given-names>A.</given-names></name></person-group> (<year>2010</year>). <article-title>Restorative approaches in Parkinson's Disease: which cell type wins the race?</article-title>
<source>J. Neurol. Sci</source>. <volume>289</volume>, <fpage>93</fpage>&#x2013;<lpage>103</lpage>
<pub-id pub-id-type="doi">10.1016/j.jns.2009.08.024</pub-id><pub-id pub-id-type="pmid">19733367</pub-id></mixed-citation>
      </ref>
      <ref id="B62">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nakao</surname><given-names>N.</given-names></name><name><surname>Frodl</surname><given-names>E. M.</given-names></name><name><surname>Duan</surname><given-names>W. M.</given-names></name><name><surname>Widner</surname><given-names>H.</given-names></name><name><surname>Brundin</surname><given-names>P.</given-names></name></person-group> (<year>1994</year>). <article-title>Lazaroids improve the survival of grafted rat embryonic dopamine neurons</article-title>. <source>Proc. Natl. Acad. Sci. U.S.A</source>. <volume>91</volume>, <fpage>12408</fpage>&#x2013;<lpage>12412</lpage>
<pub-id pub-id-type="doi">10.1073/pnas.91.26.12408</pub-id><pub-id pub-id-type="pmid">7809050</pub-id></mixed-citation>
      </ref>
      <ref id="B63">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nussbaum</surname><given-names>R. L.</given-names></name><name><surname>Ellis</surname><given-names>C. E.</given-names></name></person-group> (<year>2003</year>). <article-title>Alzheimer's disease and Parkinson's disease</article-title>. <source>N. Engl. J. Med</source>. <volume>348</volume>, <fpage>1356</fpage>&#x2013;<lpage>1364</lpage>
<pub-id pub-id-type="doi">10.1056/NEJM2003ra020003</pub-id><pub-id pub-id-type="pmid">12672864</pub-id></mixed-citation>
      </ref>
      <ref id="B64">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Olanow</surname><given-names>C. W.</given-names></name><name><surname>Goetz</surname><given-names>C. G.</given-names></name><name><surname>Kordower</surname><given-names>J. H.</given-names></name><name><surname>Stoessl</surname><given-names>A. J.</given-names></name><name><surname>Sossi</surname><given-names>V.</given-names></name><name><surname>Brin</surname><given-names>M. F.</given-names></name><etal/></person-group> (<year>2003</year>). <article-title>A double-blind controlled trial of bilateral fetal nigral transplantation in Parkinson's disease</article-title>. <source>Ann. Neurol</source>. <volume>54</volume>, <fpage>403</fpage>&#x2013;<lpage>414</lpage>
<pub-id pub-id-type="doi">10.1002/ana.10720</pub-id><pub-id pub-id-type="pmid">12953276</pub-id></mixed-citation>
      </ref>
      <ref id="B65">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Park</surname><given-names>C. H.</given-names></name><name><surname>Kang</surname><given-names>J. S.</given-names></name><name><surname>Kim</surname><given-names>J. S.</given-names></name><name><surname>Chung</surname><given-names>S.</given-names></name><name><surname>Koh</surname><given-names>J. Y.</given-names></name><name><surname>Yoon</surname><given-names>E. H.</given-names></name><etal/></person-group> (<year>2006</year>). <article-title>Differential actions of the proneural genes encoding Mash1 and neurogenins in Nurr1-induced dopamine neuron differentiation</article-title>. <source>J. Cell Sci</source>. <volume>119</volume>, <fpage>2310</fpage>&#x2013;<lpage>2320</lpage>
<pub-id pub-id-type="doi">10.1242/jcs.02955</pub-id><pub-id pub-id-type="pmid">16723737</pub-id></mixed-citation>
      </ref>
      <ref id="B66">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pesce</surname><given-names>M.</given-names></name><name><surname>Scholer</surname><given-names>H. R.</given-names></name></person-group> (<year>2001</year>). <article-title>Oct-4: gatekeeper in the beginnings of mammalian development</article-title>. <source>Stem Cells</source>
<volume>19</volume>, <fpage>271</fpage>&#x2013;<lpage>278</lpage>
<pub-id pub-id-type="doi">10.1634/stemcells.19-4-271</pub-id><pub-id pub-id-type="pmid">11463946</pub-id></mixed-citation>
      </ref>
      <ref id="B67">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pignatelli</surname><given-names>A.</given-names></name><name><surname>Kobayashi</surname><given-names>K.</given-names></name><name><surname>Okano</surname><given-names>H.</given-names></name><name><surname>Belluzzi</surname><given-names>O.</given-names></name></person-group> (<year>2005</year>). <article-title>Functional properties of dopaminergic neurones in the mouse olfactory bulb</article-title>. <source>J. Physiol</source>. <volume>564</volume>, <fpage>501</fpage>&#x2013;<lpage>514</lpage>
<pub-id pub-id-type="doi">10.1113/jphysiol.2005.084632</pub-id><pub-id pub-id-type="pmid">15731185</pub-id></mixed-citation>
      </ref>
      <ref id="B68">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Poewe</surname><given-names>W.</given-names></name></person-group> (<year>2008</year>). <article-title>Non-motor symptoms in Parkinson's disease</article-title>. <source>Eur. J. Neurol</source>. <volume>15</volume>(<issue>Suppl. 1</issue>), <fpage>14</fpage>&#x2013;<lpage>20</lpage>
<pub-id pub-id-type="doi">10.1111/j.1468-1331.2008.02056.x</pub-id><pub-id pub-id-type="pmid">18353132</pub-id></mixed-citation>
      </ref>
      <ref id="B69">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Politis</surname><given-names>M.</given-names></name><name><surname>Wu</surname><given-names>K.</given-names></name><name><surname>Loane</surname><given-names>C.</given-names></name><name><surname>Quinn</surname><given-names>N. P.</given-names></name><name><surname>Brooks</surname><given-names>D. J.</given-names></name><name><surname>Oertel</surname><given-names>W. H.</given-names></name><etal/></person-group> (<year>2012</year>). <article-title>Serotonin neuron loss and nonmotor symptoms continue in Parkinson's patients treated with dopamine grafts</article-title>. <source>Sci. Transl. Med</source>. <volume>4</volume>, <fpage>128ra141</fpage>
<pub-id pub-id-type="doi">10.1126/scitranslmed.3003391</pub-id><pub-id pub-id-type="pmid">22491951</pub-id></mixed-citation>
      </ref>
      <ref id="B70">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rhee</surname><given-names>Y. H.</given-names></name><name><surname>Ko</surname><given-names>J. Y.</given-names></name><name><surname>Chang</surname><given-names>M. Y.</given-names></name><name><surname>Yi</surname><given-names>S. H.</given-names></name><name><surname>Kim</surname><given-names>D.</given-names></name><name><surname>Kim</surname><given-names>C. H.</given-names></name><etal/></person-group> (<year>2011</year>). <article-title>Protein-based human iPS cells efficiently generate functional dopamine neurons and can treat a rat model of Parkinson disease</article-title>. <source>J. Clin. Invest</source>. <volume>121</volume>, <fpage>2326</fpage>&#x2013;<lpage>2335</lpage>
<pub-id pub-id-type="doi">10.1172/JCI45794</pub-id><pub-id pub-id-type="pmid">21576821</pub-id></mixed-citation>
      </ref>
      <ref id="B71">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Richardson</surname><given-names>R. M.</given-names></name><name><surname>Broaddus</surname><given-names>W. C.</given-names></name><name><surname>Holloway</surname><given-names>K. L.</given-names></name><name><surname>Fillmore</surname><given-names>H. L.</given-names></name></person-group> (<year>2005</year>). <article-title>Grafts of adult subependymal zone neuronal progenitor cells rescue hemiparkinsonian behavioral decline</article-title>. <source>Brain Res</source>. <volume>1032</volume>, <fpage>11</fpage>&#x2013;<lpage>22</lpage>
<pub-id pub-id-type="doi">10.1016/j.brainres.2004.10.043</pub-id><pub-id pub-id-type="pmid">15680936</pub-id></mixed-citation>
      </ref>
      <ref id="B72">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rodriguez-Gomez</surname><given-names>J. A.</given-names></name><name><surname>Lu</surname><given-names>J. Q.</given-names></name><name><surname>Velasco</surname><given-names>I.</given-names></name><name><surname>Rivera</surname><given-names>S.</given-names></name><name><surname>Zoghbi</surname><given-names>S. S.</given-names></name><name><surname>Liow</surname><given-names>J. S.</given-names></name><etal/></person-group> (<year>2007</year>). <article-title>Persistent dopamine functions of neurons derived from embryonic stem cells in a rodent model of Parkinson disease</article-title>. <source>Stem Cells</source>
<volume>25</volume>, <fpage>918</fpage>&#x2013;<lpage>928</lpage>
<pub-id pub-id-type="doi">10.1634/stemcells.2006-0386</pub-id><pub-id pub-id-type="pmid">17170065</pub-id></mixed-citation>
      </ref>
      <ref id="B73">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Roy</surname><given-names>N. S.</given-names></name><name><surname>Cleren</surname><given-names>C.</given-names></name><name><surname>Singh</surname><given-names>S. K.</given-names></name><name><surname>Yang</surname><given-names>L.</given-names></name><name><surname>Beal</surname><given-names>M. F.</given-names></name><name><surname>Goldman</surname><given-names>S. A.</given-names></name></person-group> (<year>2006</year>). <article-title>Functional engraftment of human ES cell-derived dopaminergic neurons enriched by coculture with telomerase-immortalized midbrain astrocytes</article-title>. <source>Nat. Med</source>. <volume>12</volume>, <fpage>1259</fpage>&#x2013;<lpage>1268</lpage>
<pub-id pub-id-type="doi">10.1038/nm1495</pub-id><pub-id pub-id-type="pmid">17057709</pub-id></mixed-citation>
      </ref>
      <ref id="B74">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sanchez-Danes</surname><given-names>A.</given-names></name><name><surname>Consiglio</surname><given-names>A.</given-names></name><name><surname>Richaud</surname><given-names>Y.</given-names></name><name><surname>Rodriguez-Piza</surname><given-names>I.</given-names></name><name><surname>Dehay</surname><given-names>B.</given-names></name><name><surname>Edel</surname><given-names>M.</given-names></name><etal/></person-group> (<year>2012</year>). <article-title>Efficient generation of A9 midbrain dopaminergic neurons by lentiviral delivery of LMX1A in human embryonic stem cells and induced pluripotent stem cells</article-title>. <source>Hum. Gene Ther</source>. <volume>23</volume>, <fpage>56</fpage>&#x2013;<lpage>69</lpage>
<pub-id pub-id-type="doi">10.1089/hum.2011.054</pub-id><pub-id pub-id-type="pmid">21877920</pub-id></mixed-citation>
      </ref>
      <ref id="B75">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sanchez-Pernaute</surname><given-names>R.</given-names></name><name><surname>Lee</surname><given-names>H.</given-names></name><name><surname>Patterson</surname><given-names>M.</given-names></name><name><surname>Reske-Nielsen</surname><given-names>C.</given-names></name><name><surname>Yoshizaki</surname><given-names>T.</given-names></name><name><surname>Sonntag</surname><given-names>K. C.</given-names></name><etal/></person-group> (<year>2008</year>). <article-title>Parthenogenetic dopamine neurons from primate embryonic stem cells restore function in experimental Parkinson's disease</article-title>. <source>Brain</source>
<volume>131</volume>, <fpage>2127</fpage>&#x2013;<lpage>2139</lpage>
<pub-id pub-id-type="doi">10.1093/brain/awn144</pub-id><pub-id pub-id-type="pmid">18669499</pub-id></mixed-citation>
      </ref>
      <ref id="B76">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Seidenfaden</surname><given-names>R.</given-names></name><name><surname>Desoeuvre</surname><given-names>A.</given-names></name><name><surname>Bosio</surname><given-names>A.</given-names></name><name><surname>Virard</surname><given-names>I.</given-names></name><name><surname>Cremer</surname><given-names>H.</given-names></name></person-group> (<year>2006</year>). <article-title>Glial conversion of SVZ-derived committed neuronal precursors after ectopic grafting into the adult brain</article-title>. <source>Mol. Cell. Neurosci</source>. <volume>32</volume>, <fpage>187</fpage>&#x2013;<lpage>198</lpage>
<pub-id pub-id-type="doi">10.1016/j.mcn.2006.04.003</pub-id><pub-id pub-id-type="pmid">16730456</pub-id></mixed-citation>
      </ref>
      <ref id="B77">
        <mixed-citation publication-type="book"><person-group person-group-type="author"><name><surname>Seki</surname><given-names>T.</given-names></name><name><surname>Sawamoto</surname><given-names>K.</given-names></name><name><surname>Parent</surname><given-names>J. M.</given-names></name><name><surname>Alvarez-Buylla</surname><given-names>A.</given-names></name></person-group> (<year>2011</year>). <source>Neurogenesis in the Adult Brain I: Neurobiology</source>. <publisher-loc>New York, NY</publisher-loc>: <publisher-name>Springer</publisher-name></mixed-citation>
      </ref>
      <ref id="B78">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shim</surname><given-names>J. W.</given-names></name><name><surname>Park</surname><given-names>C. H.</given-names></name><name><surname>Bae</surname><given-names>Y. C.</given-names></name><name><surname>Bae</surname><given-names>J. Y.</given-names></name><name><surname>Chung</surname><given-names>S.</given-names></name><name><surname>Chang</surname><given-names>M. Y.</given-names></name><etal/></person-group> (<year>2007</year>). <article-title>Generation of functional dopamine neurons from neural precursor cells isolated from the subventricular zone and white matter of the adult rat brain using Nurr1 overexpression</article-title>. <source>Stem Cells</source>
<volume>25</volume>, <fpage>1252</fpage>&#x2013;<lpage>1262</lpage>
<pub-id pub-id-type="doi">10.1634/stemcells.2006-0274</pub-id><pub-id pub-id-type="pmid">17234994</pub-id></mixed-citation>
      </ref>
      <ref id="B79">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sundberg</surname><given-names>M.</given-names></name><name><surname>Bogetofte</surname><given-names>H.</given-names></name><name><surname>Lawson</surname><given-names>T.</given-names></name><name><surname>Jansson</surname><given-names>J.</given-names></name><name><surname>Smith</surname><given-names>G.</given-names></name><name><surname>Astradsson</surname><given-names>A.</given-names></name><etal/></person-group> (<year>2013</year>). <article-title>Improved cell therapy protocols for parkinson's disease based on differentiation efficiency and safety of hESC-, hiPSC-, and non-human primate iPSC-derived dopaminergic neurons</article-title>. <source>Stem Cells</source>
<volume>31</volume>, <fpage>1548</fpage>&#x2013;<lpage>1562</lpage>
<pub-id pub-id-type="doi">10.1002/stem.1415</pub-id><pub-id pub-id-type="pmid">23666606</pub-id></mixed-citation>
      </ref>
      <ref id="B80">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Swistowski</surname><given-names>A.</given-names></name><name><surname>Peng</surname><given-names>J.</given-names></name><name><surname>Liu</surname><given-names>Q.</given-names></name><name><surname>Mali</surname><given-names>P.</given-names></name><name><surname>Rao</surname><given-names>M. S.</given-names></name><name><surname>Cheng</surname><given-names>L.</given-names></name><etal/></person-group> (<year>2010</year>). <article-title>Efficient generation of functional dopaminergic neurons from human induced pluripotent stem cells under defined conditions</article-title>. <source>Stem Cells</source>
<volume>28</volume>, <fpage>1893</fpage>&#x2013;<lpage>1904</lpage>
<pub-id pub-id-type="doi">10.1002/stem.499</pub-id><pub-id pub-id-type="pmid">20715183</pub-id></mixed-citation>
      </ref>
      <ref id="B81">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Takagi</surname><given-names>Y.</given-names></name><name><surname>Takahashi</surname><given-names>J.</given-names></name><name><surname>Saiki</surname><given-names>H.</given-names></name><name><surname>Morizane</surname><given-names>A.</given-names></name><name><surname>Hayashi</surname><given-names>T.</given-names></name><name><surname>Kishi</surname><given-names>Y.</given-names></name><etal/></person-group> (<year>2005</year>). <article-title>Dopaminergic neurons generated from monkey embryonic stem cells function in a Parkinson primate model</article-title>. <source>J. Clin. Invest</source>. <volume>115</volume>, <fpage>102</fpage>&#x2013;<lpage>109</lpage>
<pub-id pub-id-type="doi">10.1172/JCI21137</pub-id><pub-id pub-id-type="pmid">15630449</pub-id></mixed-citation>
      </ref>
      <ref id="B82">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Theka</surname><given-names>I.</given-names></name><name><surname>Caiazzo</surname><given-names>M.</given-names></name><name><surname>Dvoretskova</surname><given-names>E.</given-names></name><name><surname>Leo</surname><given-names>D.</given-names></name><name><surname>Ungaro</surname><given-names>F.</given-names></name><name><surname>Curreli</surname><given-names>S.</given-names></name><etal/></person-group> (<year>2013</year>). <article-title>Rapid generation of functional dopaminergic neurons from human induced pluripotent stem cells through a single-step procedure using cell lineage transcription factors</article-title>. <source>Stem Cells Transl. Med</source>. <volume>2</volume>, <fpage>473</fpage>&#x2013;<lpage>479</lpage>
<pub-id pub-id-type="doi">10.5966/sctm.2012-0133</pub-id><pub-id pub-id-type="pmid">23658252</pub-id></mixed-citation>
      </ref>
      <ref id="B83">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tritsch</surname><given-names>N. X.</given-names></name><name><surname>Ding</surname><given-names>J. B.</given-names></name><name><surname>Sabatini</surname><given-names>B. L.</given-names></name></person-group> (<year>2012</year>). <article-title>Dopaminergic neurons inhibit striatal output through non-canonical release of GABA</article-title>. <source>Nature</source>
<volume>490</volume>, <fpage>262</fpage>&#x2013;<lpage>266</lpage>
<pub-id pub-id-type="doi">10.1038/nature11466</pub-id><pub-id pub-id-type="pmid">23034651</pub-id></mixed-citation>
      </ref>
      <ref id="B84">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ubeda-Banon</surname><given-names>I.</given-names></name><name><surname>Saiz-Sanchez</surname><given-names>D.</given-names></name><name><surname>De La Rosa-Prieto</surname><given-names>C.</given-names></name><name><surname>Mohedano-Moriano</surname><given-names>A.</given-names></name><name><surname>Fradejas</surname><given-names>N.</given-names></name><name><surname>Calvo</surname><given-names>S.</given-names></name><etal/></person-group> (<year>2010</year>). <article-title>Staging of alpha-synuclein in the olfactory bulb in a model of Parkinson's disease: cell types involved</article-title>. <source>Mov. Disord</source>. <volume>25</volume>, <fpage>1701</fpage>&#x2013;<lpage>1707</lpage>
<pub-id pub-id-type="doi">10.1002/mds.23197</pub-id><pub-id pub-id-type="pmid">20574962</pub-id></mixed-citation>
      </ref>
      <ref id="B85">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wernig</surname><given-names>M.</given-names></name><name><surname>Zhao</surname><given-names>J. P.</given-names></name><name><surname>Pruszak</surname><given-names>J.</given-names></name><name><surname>Hedlund</surname><given-names>E.</given-names></name><name><surname>Fu</surname><given-names>D.</given-names></name><name><surname>Soldner</surname><given-names>F.</given-names></name><etal/></person-group> (<year>2008</year>). <article-title>Neurons derived from reprogrammed fibroblasts functionally integrate into the fetal brain and improve symptoms of rats with Parkinson's disease</article-title>. <source>Proc. Natl. Acad. Sci. U.S.A</source>. <volume>105</volume>, <fpage>5856</fpage>&#x2013;<lpage>5861</lpage>
<pub-id pub-id-type="doi">10.1073/pnas.0801677105</pub-id><pub-id pub-id-type="pmid">18391196</pub-id></mixed-citation>
      </ref>
      <ref id="B86">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Westerlund</surname><given-names>U.</given-names></name><name><surname>Svensson</surname><given-names>M.</given-names></name><name><surname>Moe</surname><given-names>M. C.</given-names></name><name><surname>Varghese</surname><given-names>M.</given-names></name><name><surname>Gustavsson</surname><given-names>B.</given-names></name><name><surname>Wallstedt</surname><given-names>L.</given-names></name><etal/></person-group> (<year>2005</year>). <article-title>Endoscopically harvested stem cells: a putative method in future autotransplantation</article-title>. <source>Neurosurgery</source>
<volume>57</volume>, <fpage>779</fpage>&#x2013;<lpage>784</lpage> discussion: 779&#x2013;784. <pub-id pub-id-type="doi">10.1227/01.NEU.0000176402.78462.cd</pub-id><pub-id pub-id-type="pmid">16239892</pub-id></mixed-citation>
      </ref>
      <ref id="B87">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Widner</surname><given-names>H.</given-names></name><name><surname>Tetrud</surname><given-names>J.</given-names></name><name><surname>Rehncrona</surname><given-names>S.</given-names></name><name><surname>Snow</surname><given-names>B.</given-names></name><name><surname>Brundin</surname><given-names>P.</given-names></name><name><surname>Gustavii</surname><given-names>B.</given-names></name><etal/></person-group> (<year>1992</year>). <article-title>Bilateral fetal mesencephalic grafting in two patients with parkinsonism induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)</article-title>. <source>N. Engl. J. Med</source>. <volume>327</volume>, <fpage>1556</fpage>&#x2013;<lpage>1563</lpage>
<pub-id pub-id-type="doi">10.1056/NEJM199211263272203</pub-id><pub-id pub-id-type="pmid">1435882</pub-id></mixed-citation>
      </ref>
      <ref id="B88">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wijeyekoon</surname><given-names>R.</given-names></name><name><surname>Barker</surname><given-names>R. A.</given-names></name></person-group> (<year>2009</year>). <article-title>Cell replacement therapy for Parkinson's disease</article-title>. <source>Biochim. Biophys. Acta</source>
<volume>1792</volume>, <fpage>688</fpage>&#x2013;<lpage>702</lpage>
<pub-id pub-id-type="doi">10.1016/j.bbadis.2008.10.007</pub-id><pub-id pub-id-type="pmid">19007882</pub-id></mixed-citation>
      </ref>
      <ref id="B89">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yi</surname><given-names>Y.</given-names></name><name><surname>Noh</surname><given-names>M. J.</given-names></name><name><surname>Lee</surname><given-names>K. H.</given-names></name></person-group> (<year>2011</year>). <article-title>Current advances in retroviral gene therapy</article-title>. <source>Curr. Gene Ther</source>. <volume>11</volume>, <fpage>218</fpage>&#x2013;<lpage>228</lpage>
<pub-id pub-id-type="doi">10.2174/156652311795684740</pub-id><pub-id pub-id-type="pmid">21453283</pub-id></mixed-citation>
      </ref>
      <ref id="B90">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Young</surname><given-names>K. M.</given-names></name><name><surname>Fogarty</surname><given-names>M.</given-names></name><name><surname>Kessaris</surname><given-names>N.</given-names></name><name><surname>Richardson</surname><given-names>W. D.</given-names></name></person-group> (<year>2007</year>). <article-title>Subventricular zone stem cells are heterogeneous with respect to their embryonic origins and neurogenic fates in the adult olfactory bulb</article-title>. <source>J. Neurosci</source>. <volume>27</volume>, <fpage>8286</fpage>&#x2013;<lpage>8296</lpage>
<pub-id pub-id-type="doi">10.1523/JNEUROSCI.0476-07.2007</pub-id><pub-id pub-id-type="pmid">17670975</pub-id></mixed-citation>
      </ref>
      <ref id="B91">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Young</surname><given-names>S. Z.</given-names></name><name><surname>Taylor</surname><given-names>M. M.</given-names></name><name><surname>Bordey</surname><given-names>A.</given-names></name></person-group> (<year>2011</year>). <article-title>Neurotransmitters couple brain activity to subventricular zone neurogenesis</article-title>. <source>Eur. J. Neurosci</source>. <volume>33</volume>, <fpage>1123</fpage>&#x2013;<lpage>1132</lpage>
<pub-id pub-id-type="doi">10.1111/j.1460-9568.2011.07611.x</pub-id><pub-id pub-id-type="pmid">21395856</pub-id></mixed-citation>
      </ref>
      <ref id="B92">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yuan</surname><given-names>S. H.</given-names></name><name><surname>Martin</surname><given-names>J.</given-names></name><name><surname>Elia</surname><given-names>J.</given-names></name><name><surname>Flippin</surname><given-names>J.</given-names></name><name><surname>Paramban</surname><given-names>R. I.</given-names></name><name><surname>Hefferan</surname><given-names>M. P.</given-names></name><etal/></person-group> (<year>2011</year>). <article-title>Cell-surface marker signatures for the isolation of neural stem cells, glia and neurons derived from human pluripotent stem cells</article-title>. <source>PLoS ONE</source>
<volume>6</volume>:<fpage>e17540</fpage>
<pub-id pub-id-type="doi">10.1371/journal.pone.0017540</pub-id><pub-id pub-id-type="pmid">21407814</pub-id></mixed-citation>
      </ref>
      <ref id="B93">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>R. L.</given-names></name><name><surname>Zhang</surname><given-names>L.</given-names></name><name><surname>Zhang</surname><given-names>Z. G.</given-names></name><name><surname>Morris</surname><given-names>D.</given-names></name><name><surname>Jiang</surname><given-names>Q.</given-names></name><name><surname>Wang</surname><given-names>L.</given-names></name><etal/></person-group> (<year>2003</year>). <article-title>Migration and differentiation of adult rat subventricular zone progenitor cells transplanted into the adult rat striatum</article-title>. <source>Neuroscience</source>
<volume>116</volume>, <fpage>373</fpage>&#x2013;<lpage>382</lpage>
<pub-id pub-id-type="doi">10.1016/S0306-4522(02)00696-6</pub-id><pub-id pub-id-type="pmid">12559093</pub-id></mixed-citation>
      </ref>
      <ref id="B94">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zuddas</surname><given-names>A.</given-names></name><name><surname>Corsini</surname><given-names>G. U.</given-names></name><name><surname>Barker</surname><given-names>J. L.</given-names></name><name><surname>Kopin</surname><given-names>I. J.</given-names></name><name><surname>Di Porzio</surname><given-names>U.</given-names></name></person-group> (<year>1991</year>). <article-title>Specific Reinnervation of lesioned mouse striatum by grafted mesencephalic dopaminergic neurons</article-title>. <source>Eur. J. Neurosci</source>. <volume>3</volume>, <fpage>72</fpage>&#x2013;<lpage>85</lpage>
<pub-id pub-id-type="doi">10.1111/j.1460-9568.1991.tb00813.x</pub-id><pub-id pub-id-type="pmid">12106271</pub-id></mixed-citation>
      </ref>
    </ref-list>
  </back>
</article>
</pmc-articleset>